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“The noblest pleasure is the joy of understanding. 
Therefore, be always curious and observant” 
 
           Leonardo Da Vinci 
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Thesis abstract 
 
The research for this thesis examined the effects of diabetic peripheral neuropathy 
(DPN) on biomechanical factors related to the risk of falling during locomotor tasks, 
and the effects of a 16-week multi-factorial intervention on the identified impairments. 
The speed of ankle and knee strength generation, and muscular activations were 
measured during stair ascent and descent; and minimum toe clearance, stepping 
accuracy, and visual gaze parameters were measured during level ground walking. 
Patients with DPN, diabetes patients with no neuropathy and non-diabetic controls 
were measured before and after a 16-week intervention consisting of high-load 
resistance exercises and a visual gaze training task. Patients with DPN displayed 
slower ankle and knee strength generation during stair ascent and descent than 
healthy controls (p<0.05). Post-intervention, strength was generated faster at the 
ankle and knee during both tasks (p<0.05), which is expected to improve stability 
during the weight acceptance phase. During level ground walking, patients with DPN 
displayed a higher minimum toe clearance (p<0.05), which is expected to reduce the 
risk of tripping on smaller, less observable hazards; but displayed a decreased 
stepping accuracy (p<0.05), which may reduce the ability to avoid tripping hazards. 
Stepping accuracy was improved as a result of the intervention (p<0.05), which may 
originate from improvements in visual gaze strategy and motor control, contributing to 
reduce the risk of tripping in patients with DPN. Biomechanical impairments during 
locomotion were observed in patients with DPN; however, the intervention improved 
these aspects and may reduce the risk of falling in this population. 
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Chapter 1 
 
Introduction 
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Background 
 
Diabetes: Definition and global prevalence 
Diabetes Mellitus describes a group of metabolic diseases that cause a chronic 
elevation in blood glucose levels (1, 2). Diabetes develops when adequate glucose 
cannot enter the cells of the body to be used as fuel, due to impairments in insulin 
secretion, insulin action, or both (1, 2). There are two different types of diabetes: type 
1 and type 2. Type 1 diabetes occurs when the body cannot produce insulin, and 
accounts for approximately 5-10% of adults with diabetes, whereas type 2 diabetes 
accounts for 85-95% of all people with diabetes, and is caused by impaired insulin 
action, which reduces the ability of cells to uptake glucose (1, 2). Type 2 diabetes 
typically affects patients who are overweight or display a high body fat percentage, a 
characteristic that has typically caused the initial development of diabetes itself (1). 
 
One in 20 people in the United Kingdom are estimated to have diabetes, with 
850,000 of these patients currently undiagnosed (2). Three hundred and forty seven 
million people worldwide have diabetes, and by 2030, this number is expected to 
dramatically increase to close to 439 million (3, 4). People with diabetes have 
approximately twice the risk for cardiovascular disease as those without diabetes, 
and as a result have an increased risk of mortality (5). The World Health Organisation 
expects that the number of diabetes related deaths will double before 2030, 
becoming the 7th leading cause of death worldwide (6). Patients with diabetes require 
at least two to three times the health-care resources to patients without diabetes, and 
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approximately 15% of health care budgets are spent on diabetes related care (3, 4). 
In 2012, diabetes cost the United States of America $245 billion, of which $69 billion 
was lost due to reduced productivity, and $176 billion was spent on direct medical 
costs (1).  
 
Consistently high blood glucose levels can lead to a number of secondary 
complications including retinopathy, nephropathy, cardiovascular disease and 
neuropathy, which in isolation or combination can seriously impact on a patient’s 
quality of life (7, 8). These complications account for a substantial proportion of the 
direct health costs, representing 72% of the total costs in the United States of 
America, and 41% of costs in the United Kingdom (9).  
 
Diabetic foot problems 
Problems with the ‘diabetic foot’ account for more hospital admissions than any other 
complication among patients with diabetes (10). The term ‘diabetic foot’ refers to a 
spectrum of disorders including the ulcerated foot, the foot at risk from ulceration, and 
the Charcot foot (11). Twenty five percent of patients with diabetes will develop a foot 
ulcer in their lifetime, which if left untreated, can lead to ischemia and infection, and 
may consequently require amputation (12, 13). Because of the high risk of foot ulcers 
and consequential infection in the diabetic population, diabetes is the most common 
underlying cause of lower extremity amputation in the US and Europe, which is 
particularly concerning as the three-year survival rate for patients undergoing a major 
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lower limb amputation is just 24%, compared to 93% in patients who have undergone 
a minor amputation or none at all (14). 
 
Prolonged and elevated plantar pressures over a bony prominence, (such as a 
hammer toe or bunion), minor foot-traumas, and neuropathy, are the leading causes 
of ulceration in patients with diabetes (15-19). Patients with diabetes however 
typically display a multitude of risk-factors for ulceration, where patients with 
neuropathy, ischemia, foot deformity calluses, limited ankle mobility and a history of 
ulcers are at the greatest risk of ulceration (10, 15, 20-24). Foot ulcers often go 
undetected as a result of sensory neuropathy, leading to a lack of early detection and 
consequently lead to infection, sepsis, necrosis and gangrene, which ultimately may 
require amputation (17, 25-27). 
 
Another serious complication of the diabetic foot is Charcot athropathy which is an 
inflammatory syndrome characterised by varying degrees of bone and joint 
disorganisation, resulting in the progressive destruction of bones and soft tissue (10, 
28). It typically manifests as undetected joint dislocations and pathological fractures 
of the bones of the feet, due to the neuropathy, which fuse in an un-natural 
arrangement, altering the architecture and function of the foot (10, 29). Similarly to 
foot ulceration, Charcot arthopathy typically remains undetected due to the effects of 
diabetic neuropathy, causing the condition to gradually increase in severity. 
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Diabetic peripheral neuropathy  
Diabetic peripheral neuropathy (DPN) is one of the most common complications of 
diabetes, affecting up to 50% of sufferers after ten years of having diabetes (30, 31). 
One in 50 people in the general population of the UK are estimated to have DPN, 
and 1 in 10 people over the age of 55 are estimated to have DPN to some degree 
(2).  
 
DPN affects sensory, motor and autonomic nerves, and is caused by neurovascular 
alterations to the nerve fibres and blood vessels supplying the nerve endings, 
resulting in reduced or absent nerve conduction (2, 32). Peripheral neuropathy is 
typically tested by assessing sensory function, using a variety of instruments to 
identify the patient’s ability to detect vibration, temperature, touch and acute pain (31, 
33). However, motor neuropathy can also be detected by measuring nerve 
conduction velocity, and such methods may be a more sensitive measure of DPN 
than tests of sensorimotor function (34, 35). Diabetic peripheral neuropathy is a 
predominantly distal condition, primarily affecting the longer nerves of the feet and 
lower legs in the early stages of the condition, and gradually affecting the more 
proximal areas of the lower limbs, the hands and distal ends of the lower arms (2, 
36). DPN is characterised by the progressive loss of somatosensorial sensitivity, 
proprioception and muscular function, and can also present as a tingling sensation 
and pain in some patients (30, 31, 37-39).  
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Effects of DPN on musculoskeletal structures and gait  
The structure and function of skeletal muscles and connective tissues are highly 
affected by the presence of DPN. Predominantly distal muscle atrophy is common in 
the lower limbs, which exacerbates reductions in muscle strength (40, 41). Patients 
with DPN also display a decreased nerve conduction velocity, and impaired 
contractile properties as a result of non-enzymatic glycation, which in tandem results 
in a slower muscle response (34, 35, 42). Furthermore, tendon tensile stiffness is 
increased, limiting the range of joint motion at the ankle and knee (43-45). During 
locomotion, patients with DPN exhibit delayed peak muscle activations, despite an 
earlier ‘switching on’ of muscles, which may lead to decreased motor control during 
walking (39, 46, 47). Muscle activations during stair negotiation tasks however are 
less conclusive, with one study identifying earlier peak activations in the lower limb 
muscles, whilst another observed no differences in comparison to a healthy control 
group (48, 49). 
 
Patients with DPN display compensatory musculoskeletal mechanisms during 
locomotion in response to the somatosensorial and motor deficits (39, 47). DPN 
patients predominantly display a hip strategy during walking. Instead of propelling the 
leg through the swing phase of gait via rapid plantar flexion of the ankle, the leg is 
instead ‘pulled’ forward using the hip flexors (50, 51). This gait strategy causes 
patients to walk at slower walking speeds, with a lower cadence, a smaller step 
length, and a wider step width (50, 52, 53). Such gait alterations have been 
suggested as being the result of subconscious mechanisms to reduce potentially 
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injurious plantar pressures that may lead to ulceration (52, 53). However, some other 
studies have identified motor changes to the plantar flexor muscles as being a key 
component leading to changes in gait (40, 50, 51). When walking on stairs, patients 
with DPN display a reduced dorsiflexion during ascent, and reduced plantar flexion 
during descent, as a result of previously described reductions in ankle joint range of 
movement (41, 49). However, to my knowledge, this is one of only two studies (48, 
49) to have examined the effects of DPN on biomechanical characteristics during 
stair negotiation tasks, with neither examining the effects of underlying muscular 
activations on characteristics which may influence fall potential. 
 
Fall risk in people with DPN 
People with DPN are five times more likely to fall than age-matched controls, with 
over half of DPN patients reporting at least one fall per year (54-56). Patients with 
DPN often display a number of factors that may explain an increased risk of falling, 
however the presence of neuropathy has been identified as an independent risk 
factor explaining the high risk of falling in the DPN population (55).  
 
Approximately 30% of hospital admissions for traumatic injuries are the result of falls, 
and are a major cause of severe fatal (40% of injuries) and non-fatal injuries (57, 58). 
An estimated 73 - 85% of falls occur in the home, with 60% of falls resulting in 
fractures (59-62). Falls during stair descent account for 60% of all fall-related deaths, 
and are three times more hazardous than stair ascent, and ten times more hazardous 
than level ground walking (63-66).  
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No epidemiological data is currently available that displays the distribution of where 
and when falls occur in patients with diabetes and diabetic peripheral neuropathy. 
Despite the absence of this data, most fatal falls occur during stair descent and 
ascent and level walking (63-66). Furthermore, it is well known that the risk of falling 
in patients with DPN is higher than is observed in the general population (54-56). 
Therefore I decided to examine the locomotor paradigms of stair negotiation and 
level ground walking 
 
Risk factors for falling during walking and stair negotiation 
During level ground walking, tripping can occur on observed and unobserved 
hazards. The incidence of trip related falls is determined primarily by the frequency of 
tripping, and not the ability to recover from a trip (67). Therefore, the most effective 
approach to identifying the risk of falling for a particular individual or population is to 
examine their ability to avoid obstacles before they become a tripping hazard (68, 
69). When an obstacle is observed, the patient must co-ordinate an appropriate 
response to avoid tripping. People with a high risk of falling are less accurate and 
more variable at stepping onto targets, which may indicate an impaired control of foot 
trajectory, which may consequently impinge on effective obstacle avoidance (68, 70, 
71). However, the potential for tripping on unobserved hazards differs, and is 
dependent upon the characteristics of normal gait. The variability and absolute 
minimum of toe clearances during gait have been reported as potential indicators for 
the risk of tripping during walking in the elderly population (71-73). The more variable 
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and lower the toe clearances, the higher the risk of the toe catching a smaller, 
unobserved obstacle during the mid-swing phase of gait. 
 
During stair ascent and stair descent, the physical and sensory demands are greater 
than during level ground walking. Due to the nature of these stair negotiation tasks, 
perturbations large enough to cause a loss of balance are almost unrecoverable; 
therefore the maintenance of a safe and stable locomotor pattern is paramount. 
During stair descent, the ankle and knee joints are critical to controlling balance with 
lower extremity joint torques required to be produced to a level much higher than 
during level walking (74-79). As well as the individual’s maximal joint torque 
capabilities, the speed at which joint torques are produced may also be an important 
factor in balance maintenance. Bento et al. (80) and La Roche et al. (81) identified 
the rate of joint torque development (RJTD) as the sole factor indicative of fall risk, 
observing that people with a history of falling display a significantly slower RJTD at 
the ankle and knee, than those without a history of falling (80, 81). However, the 
effects of RJTD on stability during stair negotiation have not yet been examined in a 
diabetic patient population. To improve the understanding of the study, and the 
subsequent application of its results by clinicians, the unit of measure ‘rate of joint 
torque development’ has been termed ‘speed of strength generation’ for the following 
chapters. 
 
Effects of resistance exercise training in patients with diabetes and other high 
fall risk populations 
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Type I, and particularly type II diabetes, can be managed by increasing the levels of 
physical activity performed. Aerobic exercise helps to improve glycaemic control, 
enhance insulin sensitivity, improve cardiovascular risk factors, and reduce the risk of 
complications (82). Furthermore, it has been suggested that combining aerobic with 
resistance exercise may be even more effective for improving glycaemic control than 
aerobic exercise alone (83-85). Aerobic exercise has also been shown to disrupt and 
slow the progression of neuropathy, by increasing branching and fibre density of 
intraepidermal nerves and reducing the decreases in nerve conduction velocity 
observed over time (86-88).  
 
Resistance exercise training increases muscle strength and volume, as well as 
altering tendon properties, and helps to control blood pressure (84, 89, 90-93). These 
adaptations contribute to an increased six minute walking distance, increased 
walking speed and increased postural stability observed in patients with diabetes 
following 12 weeks of resistance exercise training (89, 94-97). Resistance exercise 
also helps to improve psychological well being and the enjoyment of exercise 
regimens, and may aid the continued performance of exercise in patients with 
diabetes, which is important for a population whom typically display negative attitudes 
towards exercise (98, 99). No studies, however, have yet examined the effects of 
exercise for improving dynamic measures of fall potential such as the ability to rapidly 
generate strength at the ankle and knee joints, as identified above. Exercise 
interventions with the specific aim to improve RJTD in an elderly population have 
previously been suggested to be more effective at reducing the risk of falling than 
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more generalised exercises, and may therefore also be effective at reducing the risk 
of falling in patients with DPN (80).  
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Thesis aim 
 
The purpose of this thesis is to examine the effects of DPN on biomechanical 
mechanisms of locomotion that may explain an increased risk of falling during 
level ground walking and stair negotiation. Furthermore, this thesis will examine 
the effects of a targeted intervention on potential mechanisms of impairment, to 
examine whether these factors can be improved and potentially contribute to 
reducing the risk of falling in the DPN population. 
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Thesis Outline 
 
This thesis will take the form of six chapters, focusing around the presentation of 
four experimental chapters. 
 
The first two of these experimental chapters (chapters 2 and 3), examine the 
effects of diabetes and DPN on biomechanical characteristics of stair negotiation, 
which may impact upon stability, and the effects of an intervention to improve 
these characteristics. Chapter 2 specifically examines the effects of DPN on speed 
of strength generation (ability to rapidly develop strength at the joint; RJTD) at the 
knee and ankle during stair ascent and descent, and the muscular activations that 
may influence the speed of strength generation observed during these 
movements. Chapter 3 then examines the effects of a 16-week resistance 
exercise-based intervention on these characteristics in patients with diabetes and 
DPN, with the aim to improve stability during stair negotiation.   
 
Chapters 4 and 5 examine factors that may affect the ability of patients to avoid 
observed and unobserved obstacles during walking, and the efficacy of a targeted 
intervention to alter these characteristics. Chapter 4 examines the effects of 
diabetes and DPN on stepping accuracy and minimum toe clearance, which are 
indicative of the potential for tripping and preliminary measures of visual gaze 
parameters, which may help to explain the underlying characteristics of stepping 
accuracy. Chapter 5 then investigates the effects of a targeted multifactorial 
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intervention on improving stepping accuracy in patients with diabetes and DPN, 
and discusses the implications of this on the potential for tripping on observed 
obstacles. 
  
A priori power calculation performed using the parameter of ankle joint torque 
originally identified requirements for 18 participants in each of the three groups for 
identification of the pre-intervention between group differences, and 18 participants 
were also required in each group to identify pre-post intervention within group 
differences. Post-hoc power calculations were performed where these group 
numbers were not achieved. 
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Chapter 2  
 
A stairway to heaven? Contributory factors to unsteadiness during 
walking up and down stairs in patients with diabetic peripheral 
neuropathy 
 
 
 
 
 
 
 
 
 
Page | 45  
 
Abstract 
 
Introduction: Although patients with diabetic peripheral neuropathy (DPN) are more 
likely to fall than age-matched controls, the underlying causative factors are not yet 
fully understood. This study examines the effects of diabetes and neuropathy on 
strength generation and muscle activation patterns during walking up and down 
stairs, with implications for fall risk. 
  
Methods: Sixty three participants; 21 patients with DPN, 21 diabetic controls (D), and 
21 healthy controls (C) were examined whilst walking up and down a custom-built 
staircase. The speed of strength generation at the ankle and knee and activation 
patterns of the ankle and knee extensor muscles were analyzed.  
 
Results: Patients with DPN displayed significantly slower ankle and knee strength 
generation than healthy controls, during stair ascent and descent (p<0.05). During 
ascent, the ankle and knee extensor muscles were activated significantly later by 
patients with DPN, and took longer to reach peak activation (p<0.05). During 
descent, neuropathic patients activated the ankle extensors significantly earlier, and 
the ankle and knee extensors took significantly longer to reach peak activation 
(p<0.05). 
 
Discussion: Patients with DPN are slower at generating strength at the ankle and 
knee than control participants during walking up and down stairs. These changes, 
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which are likely caused by altered activations of the extensor muscles, increase the 
likelihood of instability and may be important contributory factors for the increased 
risk of falling. Resistance exercise training may be a potential clinical intervention for 
improving these aspects, and thereby potentially reducing fall risk.   
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Introduction 
 
Diabetic peripheral neuropathy (DPN) is a chronic complication of diabetes, affecting 
up to 50% of older patients (1, 2). It is characterised by sensory loss in the lower 
limbs, altered sense of joint position, and impaired muscular function, which can 
result in alterations to gait (1-5).  Patients with neuropathy are five times more likely 
to fall than age-matched controls, with over half of patients reporting at least one fall 
per year (6, 7). Falls whilst walking down stairs account for 60% of all fall-related 
deaths, making this activity ten times more hazardous than level ground walking (8). 
Thus the common daily task of negotiating stairs poses a high fall risk for people with 
diabetes, and particularly those with peripheral neuropathy.  
 
During walking up and down stairs (ascending and descending), the major muscles 
surrounding the ankle and knee joints generate strength at the joint, controlling the 
movement of the body. The speed at which joint strength is produced is an important 
factor related to unsteadiness, with a slower generation of joint strength indicative of 
a higher risk of falling (9-11). When walking on stairs, and particularly when walking 
down stairs, it is very difficult to recover balance following a moment of unsteadiness. 
Therefore, it is of importance to reduce any marked unsteadiness, to prevent a fall 
occurring on stairs. Patients with diabetic neuropathy display slower joint strength 
generation when balance is challenged while standing on one leg (12, 13). This may 
have implications for during the single leg stance phases of walking up and down 
stairs, and could therefore explain the increased chance of falling in this population. 
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Joint strength, and the speed at which it is generated, are the result of muscular 
forces surrounding the joint. During stair walking, the ankle and knee extensors are 
the primary muscles controlling the motion of the body (14-16). The timing of when 
these muscles are ‘switched on’ (activated), is therefore key to the safe performance 
of these movements. Previous studies examining muscle activation patterns in 
patients with DPN have been inconclusive due to differing measurement techniques, 
with earlier activations, and later peak activations of the ankle extensors observed 
during level ground walking (17, 18). During stair climbing, the peak activations of the 
ankle and knee extensors have been observed to be earlier, yet the time when 
muscles ‘switch on’ (muscle activation onset) has not yet been measured (19). A 
better understanding of how diabetic neuropathy affects lower limb muscle 
activations and the resulting gait alterations can be gained via understanding when 
specific muscles ‘switch on’, when they reach ‘full’ activation, and how long they are 
‘switched on’ for.  
 
The aim of this study was to examine the effects of diabetes and DPN on the speed 
of joint strength generation and muscle activation patterns during walking up and 
down stairs (ascent and descent). Here we address the hypothesis that the lower 
limb muscles of diabetic patients will respond more slowly and be slower to develop 
the required strength when initially contacting the floor or step during stair walking. 
We hypothesise that this impaired muscular response will be an important factor 
contributing to unsteadiness and that this will be particularly evident on stairs where 
the physical demands are extremely high compared to level ground walking.    
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Methods 
 
Participants 
Sixty-three participants; 21 patients with DPN (Age: 57.6 ± 9.4 years; and BMI: 30.1 ± 
5.1 kg.m-1; mean ± SD), 21 patients with diabetes but no peripheral neuropathy (Age: 
57.5 ± 12.7 years; and BMI: 28.1 ± 3.0 kg.m-1) (D) and 21 healthy control participants 
(Age: 57.6 ± 12.5 years; and BMI: 26.1 ± 3.9 kg.m-1)(C) matched for age, gave their 
written informed consent to participate in this study, which was given ethical approval 
from the relevant bodies. Patients were recruited through the Manchester diabetes 
centre, as a result of a local radio show interview, the local newspaper, and through 
an initiative called Help Beat DiaBEATes. (Patients were recruited through these 
avenues for all aspects of this thesis). The major exclusion criteria were: open ulcers, 
requiring the use of a walking aid, a history of any other disorders affecting gait, and 
a visual acuity of <6/18 (of any aetiology, including retinopathy).  
 
Neuropathy assessment & classification 
The presence and severity of neuropathy was measured using separate tests: the 
Modified Neuropathy Disability Score (mNDS)(Fig. 1)(1, 2), and the Vibration 
Perception Threshold (VPT)(1, 2) using a neurothesiometer (Bailey Instruments Ltd. 
Manchester, UK). Patients with no neuropathy (defined by mNDS ≤5 and VPT ≤24) 
were grouped as D, and those with moderate to severe neuropathy (defined by 
mNDS ≥6 and VPT ≥25) were grouped as DPN (1, 2). 
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Figure 1. The modified neuropathy disability score. Boulton 2004 (1, 2) 
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Design 
Participants ascended and descended a bespoke eight-step staircase with four step-
embedded force platforms in the middle four steps of the staircase. A ten-camera 
motion capture system captured whole body movements (Vicon, Oxford, UK) and 
ground reaction forces were measured from the step-embedded force platforms 
(Kistler, Winterthur, Switzerland). Motion and force data were recorded 
simultaneously at 120Hz and 1,000Hz, respectively. Muscle activity was assessed 
from representative lower limb muscles, using wireless electromyographic surface 
electrodes (Delsys, Boston, USA) recording at 1,000Hz. The analogue signals from 
the electrodes were synchronised with the Vicon motion capture system and force 
platforms. 
 
Procedure  
Preparation 
Fifty seven retro-reflective markers were attached to the participant’s body according 
to standard motion analysis preparation methods, creating a 15 segment whole body 
model, of which the seven segments of the lower body were used in this study 
(pelvis, thighs, shanks and feet)(4, 14) To ensure the reliability of marker placement, 
all markers were placed on the participants by myself on bony landmarks and on 
areas of the body which are least affected by soft tissue movement, such as on the 
tibia for the shank, for example. All participants wore specialist diabetic shoes 
(MedSurg, Darco, Raisting, Germany), with a neutral foot-bed to standardise 
footwear between groups, and to ensure that the diabetic patients walked with 
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appropriate footwear. A brief period of acclimatization to the footwear was provided 
before testing began. 
 
The electromyographic electrodes to measure muscle activations were placed on the 
skin over the muscles representative of the major knee and ankle extensors: the 
vastus lateralis (knee extensors; KE) and medial gastrocnemius (ankle extensors; 
AE) of both legs.  
 
Stair negotiation 
Participants ascended and descended an eight-step staircase, with a step width of 
1050mm, depth of 275mm and a step riser height of 175mm. The staircase was 
instrumented with four force plates (500mm x 275mm; Kistler, Winterthur, 
Switzerland) embedded into the middle four steps. Participants were asked to walk 
without the use of the handrails, but were told to use them if they felt unsafe or 
unsteady. Trials were disregarded if handrails were used momentarily in trials. The 
use of handrails was prevented to restrict confounding factors which may affect 
measurements of speed of strength generation. Handrails can alter the production of 
joint moments (Reeves 2008), which may then distort the results depending on the 
strategy of how they are used. In everyday life, whilst they typically will be available, 
in some situations handrails may not always be present. Therefore, during such 
scenarios, patients with DPN may be at the highest risk of falling. Participants 
ascended and descended the staircase until five ascents and five descents were 
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recorded, and all force plates were contacted by the whole foot, with no part 
overhanging onto either side of the step.  
 
Level walking 
As a reference condition for comparison with stair negotiation, participants were 
asked to walk along an 8m long walkway with three embedded force plates (Kistler, 
Winterthur, Switzerland). Participants were required to repeat the movement until five 
trials were captured, in which the participants struck one of the force plates with the 
whole of the foot inside the borders of the force plate. 
 
Data analysis 
Speed of strength generation  
Speed of strength generation (SoSG) at the ankle and knee was measured as the 
rate at which joint torque was developed (RJTD). A joint torque is the turning force of 
the joint, and both causes and controls of movement. Therefore the speed at which 
this force is developed is indicative of the speed at which strength is generated at the 
joint. 
 
Individual trials were labeled in Vicon Nexus software (Vicon, Oxford, UK). The three 
most complete trials (in terms of marker presence during the trial) for each person, in 
each paradigm, were then exported into Visual3D (C-Motion Inc, MD, USA) for 
analysis. Joint torques were normalized to body mass to enable valid group 
comparisons.  
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The RJTD of the support leg was calculated using the gradient of the joint torque-
time curve for the ankle and knee. In each stair trial, the joint torque values from each 
of the four embedded steps were used and the mean taken. However, in some trials 
not all values were available from all four force plates, so as many were used as 
possible.   
 
Muscle activation 
The same trials used for RJTD analysis were used for the muscle activation analysis. 
The muscle activation (electromyographic) signals were examined from the leg of the 
foot contacting the upper middle step of the eight-step staircase. Two stages of 
analysis were performed, the first stage identified when the activation of the muscle 
began and ended (defined as onset and cessation, respectively), and the second 
stage identified the peak of the muscle activity profile. In the first stage, the raw 
muscle activation signals were processed using a bespoke Matlab (Matlab v2008b, 
Mathworks, Natick, Massachusetts, USA) programme, as detailed previously by 
Buckley et al. (20), which identified when muscles are ‘switched on and off’ (onset 
and cessation, respectively). The second stage identified muscle activation peaks of 
each muscle in Visual 3D. The signal was processed using a full wave rectification, a 
linear envelope with three window frames, and a Butterworth low pass filter with a 
cut-off frequency of 4Hz. The peak of the signal for each of the VL and GN muscles 
was then recorded with respect to foot-step contact. To enable accurate comparisons 
between groups, the commonly dominant peak was measured. The time at which the 
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peak occurred in reference to foot-step contact was measured and defined as the 
time of peak (TOP), as well as the time difference between the onset of muscle 
activity and the peak of activity, defined as the time to peak (TTP). Muscle activation 
timings were presented as bars of activations (Fig. 2).  
 
 
 
 
 
Figure. 2. Example diagram of a stair descent trial from a single participant to 
illustrate how the muscle activation parameters have been derived from the muscle 
activation signals (electromyographic activity). The top panel displays the processed 
muscle activation signals from the knee extensor muscle (KE; measured as vastus 
lateralis, VL).  The corresponding activation bar (lower panel) illustrates how 
activation parameters are derived for the results: the start of the bars show the 
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muscle onset, the change in colour indicates the point at which the peak activation 
occurs and the end of the bars denotes the muscle cessation. The measurements of 
time of peak (TOP) and time to peak (TTP) are illustrated by the arrows above the KE 
bar.  
 
Statistics 
All statistical tests were performed on SPSS statistical package (SPSS v18, Chicago, 
Illinois) with significance set at p<0.05. Mean group differences in both speed of 
strength generation (RJTD), and muscle activation onset, TOP, TTP, and muscle 
activation duration, were all statistically tested using a one-way analysis of variance 
(ANOVA) with a Bonferoni post-hoc test, and all significances are reported with 
respect to the control group. Between gait tasks (stair ascent, stair descent and level 
walking), differences (mean across all groups) were also tested using a repeated 
measures ANOVA with a Bonferoni post-hoc test, with all significances for this 
comparison reported with respect to level ground walking. Only participants who 
completed all three gait tasks were used for this comparison.  
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Results 
 
mNDS and VPT scores 
Patients with neuropathy displayed significantly higher mNDS (C: 1.4 ± 1.3; D: 1.9 ± 
1.7; DPN: 7.6 ± 3.0; p<0.05) and VPT (C: 9.4 ± 5.8; D: 9.2 ± 4.7; DPN: 31.5 ± 9.8 V; 
p<0.05) scores than the C and D groups. There were no differences (p>0.05) in the 
mNDS or VPT between C and D groups, underlining that this diabetes group had no 
neuropathy.  
 
Gait velocity 
The patients with diabetes (D and DPN groups) performed stair ascent (C: 0.48 ± 
0.07; D: 0.43 ± 0.07; DPN: 0.38 ± 0.08 m.s-1; p<0.05), stair descent (C: 0.53 ± 0.09; 
D: 0.44 ± 0.09; DPN: 0.41 ± 0.11 m.s-1; p<0.05) and level walking (C: 1.39 ± 0.19; D: 
1.27 ± 0.18; DPN: 1.18 ± 0.27 m.s-1; p<0.05) at significantly slower velocities than the 
control group. 
 
Speed of strength generation (Fig. 3) 
During stair ascent, the D and DPN groups displayed significantly slower ankle and 
knee strength generation than the C group (Fig. 3). During stair descent, the D and 
DPN groups displayed significantly slower knee strength generation than the C 
group; the DPN group also displayed significantly slower ankle strength generation 
than the C group. 
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SoSG was significantly higher at both the ankle (Level: 3.8 ± 1.3; Ascent: 5.1 ± 3.07; 
Descent: 8.7 ± 2.9 Nm.kg.s-1; p<0.05) and knee (Level: 8.2 ± 2.6; Ascent: 10.8 ± 4.0; 
Descent: 10.7 ± 4.5 Nm.kg.s-1; p<0.05) during stair ascent and stair descent, 
compared to level walking, for all groups. An analysis of covariance was also 
performed using gait velocity as a covariate. The results of this further analysis still 
showed that patients with diabetes and diabetic peripheral neuropathy generated 
significantly slower speeds of strength generation compared to controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 59  
 
 
 
 
 
Figure. 3. Ankle and knee speed of strength generation (rate of joint torque 
development; RJTD) during stair ascent and stair descent for controls (C; n=21), 
diabetes patients with no neuropathy (D; n=21) and patients with diabetic peripheral 
neuropathy (DPN; n=21). The corresponding values obtained for level ground 
walking are indicated on each bar by the horizontal white/black lines. Light grey bars 
show the mean ankle speed of strength generation and dark grey bars the mean 
knee speed of strength generation. Values are means and standard deviations. * 
denotes significantly different compared to control group (p<0.05). 
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Muscle activations during stair ascent (Fig. 4) 
During stair ascent, the DPN group activated both the knee and ankle extensor 
muscles significantly later than the C group (Fig. 4). The activation peak occurred 
later for DPN patients in the knee extensors (TOP: C: 0.13 ± 0.05; D: 0.13 ± 0.05; 
DPN: 0.19 ± 0.10s; p<0.05) and ankle extensors (C: 0.61 ± 0.13; D: 0.66 ± 0.13; 
DPN: 0.86 ± 0.27s; p<0.05), resulting in a longer time to reach peak activation (TTP) 
for the knee extensors, by the DPN group, but no differences were observed for the 
ankle extensors. The patients with DPN activated the knee extensors for significantly 
longer than the C group, whilst no differences were observed between the groups for 
the activation duration of the ankle extensors. 
 
Muscle activations during stair descent (Fig. 5) 
During stair descent, the DPN group activated the ankle extensors earlier than the C 
group, whilst the knee extensors were activated at a similar time in all groups (Fig. 5). 
Once activated, the knee and ankle extensors took significantly longer to reach their 
peak activation (TTP) in both the D and DPN groups compared to the C group. The 
peak activation of the knee extensors by the DPN group occurred significantly later 
after foot-step contact (TOP: C: 0.49 ± 0.13; D: 0.62 ± 0.12; DPN: 0.67 ± 0.26s; 
p<0.05), whilst the ankle extensors reached full activation at similar times between 
groups (TOP: C: 0.06 ± 0.05; D: 0.07 ± 0.05; DPN: 0.05 ± 0.06s; p<0.05). The D and 
DPN groups also activated the knee and ankle extensors for significantly longer in 
total.  
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Figure 4. Periods of activation for the knee extensor (KE; vastus lateralis) and ankle 
extensor (AE; medial gastrocnemius) muscles with respect to foot-step contact 
(occurring at time zero) during stair ascent. Values are means and SD for healthy 
controls (C; n=21), diabetes patients with no neuropathy (D; n=21) and patients with 
diabetic peripheral neuropathy (DPN; n=21). * denotes significantly different (p<0.05) 
timings compared to control group. Significance is shown for onset (asterisk before 
activation), time to peak (asterisk above/below point of peak), and duration timings 
(asterisk after activation). For definition of the measured parameters see Fig. 2. 
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Figure 5. Periods of activation for the knee extensor (KE; vastus lateralis) and ankle 
extensor (AE; medial gastrocnemius) muscles with respect to foot-step contact 
(occurring at time zero) during stair descent. Values are means and SD for healthy 
controls (C; n=21), diabetes patients with no neuropathy (D; n=21) and patients with 
diabetic peripheral neuropathy (DPN; n=21). * denotes significantly different (p<0.05) 
timings compared to control group. Significance is shown for onset (asterisk before 
activation), time to peak (asterisk above/below point of peak), and duration timings 
(asterisk after activation). For definition of the measured parameters see Fig. 2. 
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Discussion 
 
People with diabetes, and to a greater extent, patients with neuropathy, displayed 
significantly slower strength generation at both the ankle and knee joints, and altered 
muscle activation timings during stair ascent and stair descent. The slower strength 
generation observed in people with diabetes, and particularly in patients with 
neuropathy, is likely to be a major factor explaining why this population is at a higher 
risk of falling than aged-matched controls (6, 7). The slower strength generation in 
diabetes patients, both with and without neuropathy, likely results from alterations in 
muscle activation patterns as discussed below in detail.  
 
Patients with neuropathy generate ankle and knee strength at a significantly slower 
rate than a control population during the everyday tasks of stair ascent and stair 
descent (Fig. 3). Those with diabetes but without neuropathy also displayed slower 
ankle and knee SoSG during these tasks, but not to the same extent as the patients 
with moderate-severe neuropathy. The reduced SoSG at both the ankle and knee 
joints is expected to result from a combination of reduced sensory and motor function 
as a result of polyneuropathy. Due to the reduction, or complete absence, of sensory 
and proprioceptive information transmitted to the central nervous system from the 
lower limbs, adequate motor responses cannot be properly coordinated to control 
movement. Essentially, as patients with sensory neuropathy cannot ‘feel’ when they 
contact the ground/step they may be inaccurate in the initiation of appropriate 
muscular responses. Furthermore, neuropathy patients commonly exhibit a variety of 
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motor deficits in the muscle, including reduced motor nerve conduction velocity, 
denervation of motor units (predominantly in type II muscle fibres), reduced muscle 
volume and impaired contractile properties as a result of non-enzymatic glycation 
(21-24). The combination of these factors is expected to impact on muscle response 
and subsequently slow the speed at which strength can be generated at the affected 
joints.  Non-neuropathic diabetic patients also display some of the aforementioned 
factors before sensory characteristics are altered by marked neuropathy (25), which 
may therefore explain the reduced speed at which diabetes patients without 
neuropathy (D group) generate joint strength, albeit to a lesser extent than observed 
in patients with neuropathy (Fig. 3). A slower SoSG has been shown to be a limiting 
factor to balance recovery during challenges to balance while standing on one leg, a 
movement similar to the weight acceptance phase of stair negotiation tasks (12, 13, 
26). Therefore the decreased SoSG observed in patients with neuropathy is 
expected to reduce their capability to adapt to a perturbation in balance, and may 
therefore limit the speed at which the stair walking tasks can be performed safely by 
patients with diabetes.  
 
The timing of when major muscles are first activated and when they reach their peak 
activation (the parameters of TTP and the TOP, see Fig. 2 for definition of these 
variables), are expected to directly influence the resultant speed at which joint 
strength can be generated. During stair ascent, the delayed activation (switching on) 
of the knee extensors (represented by the VL muscle) and ankle extensors 
(represented by the GN muscle) by the patients with DPN, may be related to 
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insufficient sensory feedback, hindering the patient’s ability to detect when foot-step 
contact occurs (Fig. 4). Once activated, these muscles take significantly longer to 
reach their peak activation. In the knee extensors, this may indicate why strength 
generation was slower at the knee during this movement in patients with neuropathy 
(Fig. 3). The same may also be applicable to the ankle extensors, however, during 
stair ascent, the later peak measured from the gastrocnemius muscle, is more 
attributable to the propulsive ankle extension rather than the absorptive control of 
ankle flexion observed during weight acceptance.  
 
During stair descent, changes are primarily observed in the ankle extensors with a 
significantly earlier activation, a longer time to reach peak activation (TTP) and longer 
duration of activation (Fig. 5). The earlier activation of the ankle extensors in patients 
with DPN is expected to be an anticipatory mechanism, preparing the ankle joint to 
stabilise before contact with the step actually occurs. Upon foot-step contact, the 
ankle extensors are slower to reach peak activation in patients with DPN than the 
controls. This is expected to be an influential factor leading to the reduced speed at 
which ankle strength is generated by people with neuropathy. The patients with 
neuropathy also displayed a longer time to reach peak activation (TTP) in the knee 
extensors, but similarly to during stair ascent, the peak observed in the secondarily 
activated muscle is related to the propulsive knee extension rather than the strength 
generated during the weight acceptance phase to control knee flexion. These altered 
muscle activations are expected to exert a major influence upon the speed at which 
strength can be generated, particularly the activation onset (switching the muscle on) 
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and the time to reach peak muscle activation. The consequential decreases in speed 
of strength generation, would likely lead to an increase in potentially hazardous 
perturbations to balance during stair negotiation tasks, which may then ultimately 
result in falls. 
 
The present muscle activation findings contrast with previous findings that the TOP 
occurs significantly later at both the ankle and knee during both stair ascent and 
descent (19). These differences may be because the present data are presented in 
absolute time, whereas the previous study presented their results as a percentage of 
stance phase. Although people with diabetes walk more slowly and therefore have a 
longer stance phase, the activation of muscles and the appropriate speed of strength 
generation need to occur within a given absolute time-period upon weight 
acceptance to ensure avoidance of a perturbation to balance. Therefore, I deem that  
the  presentation of these parameters in absolute time is the most relevant for 
interpretation of fall risk in this population. These activations and their timings can 
therefore only be validly measured in absolute time, especially the onset of the 
activation and the TTP, which have been highlighted as key variables influencing the 
speed of strength generation (RJTD). 
 
During both stair negotiation tasks, there is a distinct pattern of a primary muscle 
group controlling balance during weight acceptance, followed by a secondary muscle 
group controlling balance during propulsion. During stair descent, the ankle 
extensors of the support leg control the acceleration of the body’s centre of mass 
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during weight acceptance, whilst the knee extensors, activated later, are used 
primarily to control the propulsive movement during terminal stance. Conversely, 
during stair ascent, the knee extensors of the support leg are activated during weight 
acceptance to steady the body upon foot-step contact, whilst the ankle extensors are 
activated much later to control balance during the propulsion phase. In both stair 
ascent and stair descent, the ankle and knee were required to generate joint strength 
at a faster speed than during level ground walking (Fig. 3), further highlighting the 
increased physical demands required to perform stair negotiation safely. This 
corroborates with previous observations of higher absolute joint strength (measured 
as joint torque) being required during stair negotiation tasks than during level ground 
walking in non-diabetic populations (16, 20, 27). This may further explain why stair 
ascent and, particularly stair descent, are such hazardous everyday activities, and 
therefore pose the highest risk for falls in patients with diabetes and peripheral 
neuropathy. 
  
Previous studies have shown that targeted resistance training can improve muscle 
power, strength and SoSG in high fall risk populations such as the elderly (28-30). 
Such training has been shown to reduce the difficulty of performing everyday tasks, 
decrease the risk of falling, and consequently cut subsequent hospital admissions 
(29, 31). Therefore, it is suggested that such training may favourably alter muscle 
activations and increase the speed of ankle and knee strength development in 
people with DPN, potentially reducing the risk of falling and improving safety during 
the everyday task of stair walking. 
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Chapter 3 
 
Harder, better, faster, stronger: Resistance exercise training 
increases lower limb speed of strength generation during stair 
ascent and descent in patients with diabetic peripheral neuropathy  
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Abstract 
 
Introduction: Patients with diabetic peripheral neuropathy (DPN) display a slower 
speed of strength generation (SoSG) at the ankle and knee, which leads to 
unsteadiness during stair negotiation tasks. This study examines the effects of a 16-
week resistance exercise training intervention in patients with DPN on ankle and 
knee SoSG during stair ascent and descent.  
 
Methods: Forty three participants: 9 patients with DPN; 13 patients with diabetes but 
no neuropathy (D) and 21 healthy controls (H-CON) ascended and descended a 
custom-built staircase. The SoSG of the ankle and knee, and muscle activation 
patterns of the ankle and knee extensor muscles were analyzed before and after a 
16-week intervention period. 
 
Results: Ankle and knee SoSG during both stair ascent and descent were 
significantly higher post-intervention compared to pre-intervention in the diabetes 
patients who undertook the resistance exercise intervention (p<0.05). Although 
muscle activations were altered by the intervention, there were no observable 
patterns that underpinned the increases in SoSG. 
 
Discussion: The increased SoSG of the ankle and knee observed after the 
intervention, are expected to improve stability during the crucial weight acceptance 
phase of stair ascent and descent, and ultimately contribute towards reducing the risk 
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of falling. Improvements in strength as a result of the resistance exercise training 
intervention are expected to be the most influential factor for increasing the SoSG. It 
is advocated that these exercises could be incorporated into a multi-faceted exercise 
programme to improve safety in people with diabetes and DPN. 
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Introduction 
 
Diabetic peripheral neuropathy (DPN) is a chronic complication of diabetes, affecting 
up to 50% of older patients (1, 2).  Patients with DPN are five times more likely to fall 
than age-matched controls, with over half of patients reporting at least one fall per 
year (3, 4). Falls whilst walking down stairs account for 60% of all fall-related deaths, 
making this activity ten times more hazardous than level ground walking (5). 
Therefore, a means to reduce the number of falls in this population, may reduce the 
number of patients suffering serious injury, and potentially contribute towards saving 
lives.  
 
When walking on stairs, and particularly when walking down stairs, it is very difficult 
to recover balance following a moment of unsteadiness. It is therefore of the utmost 
importance to reduce this unsteadiness, to prevent a fall occurring on stairs. The 
speed at which joint strength is produced is an important factor related to 
unsteadiness, with a slower speed of strength generation (SoSG) indicative of a 
higher risk of falling (6-8). I have previously shown that during stair ascent and stair 
descent, patients with DPN display significantly slower SoSG at the ankle and knee 
upon initial step contact, compared to controls (9). This may therefore lead to 
unsteadiness during stair walking, and consequently increase the risk of falling during 
stair ascent and stair descent. 
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The speed at which joint strength is generated, is the result of muscular forces 
surrounding the joint. During stair walking, the ankle and knee extensors are the 
primary muscle groups controlling the motion of the body (10-12). The timing of 
when, and the speed at which, these muscles are ‘switched on’ (activated) are 
therefore key to the safe performance of these movements. I have previously 
identified that significantly altered muscle activation patterns in patients with DPN 
may be related to the slower SoSG observed in this population (9). Therefore, if the 
timing and speed of muscle activations can be positively modified in patients with 
DPN, the SoSG may consequentially be increased during stair ascent and descent, 
which may in turn reduce the risk of falling.  
 
Cardiovascular and resistance exercises, have been shown to improve glycaemic 
control and increase gait speed, six minute walking distance, and daily step counts 
(13-18).  However, whilst a number of studies have looked at the effects of exercise 
on postural sway during standing and gait characteristics during level ground walking, 
in patients with diabetes, no studies have yet examined the effects of resistance 
exercise training on factors affecting unsteadiness during the physically challenging 
and dangerous tasks of stair ascent and descent. Previous studies have shown that 
targeted resistance exercise training can improve the speed of strength generation in 
healthy young and older adults, which is expected to decrease the risk of falling (6, 
19, 20). It is hypothesised that such training may therefore increase the speed of 
ankle and knee strength development in people with diabetes and DPN, potentially 
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reducing the risk of falling and improving safety during the everyday task of stair 
walking.   
 
The aim of this study was to investigate the effects of a resistance exercise training 
intervention on the SoSG at the knee and ankle joints, and muscle activation timings 
of the knee and ankle extensors in patients with diabetes and DPN. It was 
hypothesised that improvements in muscle strength and increases in the speed of 
muscle activations would facilitate a faster SoSG, which would be indicative of a 
safer, more stable movement pattern during stair ascent and stair descent.  
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Methods 
 
Participants 
Forty three participants; 9 patients with DPN (Age: 57.9 ± 9.5 years; and BMI: 28.1 ± 
4.0 kg.m-1; mean ± SD) 13 patients with diabetes but no neuropathy [D] (Age: 60.3 ± 
10.0 years; and BMI: 28.3 ± 4.1 kg.m-1) and 21 healthy controls [H-CON](Age: 66.3 ± 
11.5 years; and BMI: 25.1 ± 3.1 kg.m-1), gave their written informed consent to 
participate in this study, which was given ethical approval from the relevant bodies. A 
healthy non-diabetic control group was included to provide a reference condition, 
displaying ‘optimal’ performance and providing a comparison to pre- and post-
intervention characteristics of patients with diabetes and DPN. The major exclusion 
criteria were: open ulcers, requiring the use of a walking aid, a history of any other 
disorders affecting gait, and a visual acuity of <6/18 (of any aetiology, including 
retinopathy). 
 
Neuropathy assessment & classification 
The presence and severity of neuropathy was measured using two separate tests: 
the modified Neuropathy Disability Score (mNDS)(1, 2), and the Vibration Perception 
Threshold (VPT) (1, 2) using a neurothesiometer (Horwell, Nottingham, UK). Patients 
were deemed to have moderate to severe neuropathy, and grouped as DPN if in 
either one or both of their feet they displayed either an mNDS score of ≥6, or a VPT 
of ≥25 Volts (or both). Patients were deemed to have no neuropathy and were 
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grouped as D, if in both feet they displayed scores for the mNDS of ≤5 and for the 
VPT of ≤24 Volts (1, 2). 
 
Study design 
Participants ascended and descended a bespoke eight-step staircase with four step-
embedded force platforms in the middle four steps of the staircase. A ten-camera 
motion capture system captured whole body movements (Vicon, Oxford, UK) and 
ground reaction forces were measured from the step-embedded force platforms 
(Kistler, Winterthur, Switzerland). Motion and force data were recorded 
simultaneously at 120Hz and 1,000Hz, respectively. Muscle activity was assessed 
from representative lower limb muscles, using wireless electromyographic surface 
electrodes (Delsys, Boston, USA) recording at 1,000Hz. The analogue signals from 
the electrodes were synchronised with the Vicon motion capture system and force 
platforms.  
 
Procedure  
Gait laboratory preparation 
Fifty seven retro-reflective markers were attached to the participant’s body according 
to standard motion analysis preparation methods, creating a 15 segment whole body 
model. All participants wore specialist diabetic shoes (MedSurg, Darco, Raisting, 
Germany), with a neutral foot-bed to standardise footwear between groups, and to 
ensure that the diabetic patients walked with appropriate footwear. A brief period of 
acclimatization to the footwear was provided before testing began. 
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The electromyographic electrodes to measure muscle activations were placed on the 
skin over the muscles representative of the major knee and ankle extensors: the 
vastus lateralis (knee extensors; KE) and medial gastrocnemius (ankle extensors; 
AE) of both legs.  
 
Stair negotiation 
Participants ascended and descended the staircase until at least five ascents and 
five descents were recorded, with adequate rest between trials. All participants were 
supported in a harness for safety in case of a fall, and were asked to not use the 
handrails unless they felt unable to complete the task safely without, in which case 
light handrail use was permitted. Data were not analyzsed from trials where handrails 
were used intermittently (and another trial was used for analysis instead).  
 
Resistance exercise training intervention 
Diabetes patients were randomly allocated into either the intervention group or a 
control group (who did not take part in the resistance exercise training) using a 
random number generator, with a weighting of 2:1 into the intervention and control 
groups, respectively. Sixteen participants were allocated into the intervention group 
(splitting into D-INT, n=10; and DPN-INT, n=6 groups for the purpose of data 
analysis), and six (D: n=3; DPN: n=3) were allocated into the diabetic control group 
(combined D-CON group for the purpose of data analysis). To determine the 
adequacy of the group samples in the present study, the statistical power to detect 
pre- to post-intervention differences (using the parameter knee SoSG during stair 
Page | 83  
 
descent) was tested post-hoc for the DPN-INT group (n=6). The statistical power was 
found to be 0.93, indicating the study was well powered to identify true differences 
with these specific parameters.  
 
Patients in the intervention group attended a weekly, one-hour session for 16 weeks 
(21, 22), at a private gym dedicated for research studies within the research institute 
of the university. After the 16-week intervention period, patients repeated the stair 
negotiation task, and pre- and-post intervention measurements were analysed. The 
post-intervention test took place within one month of the last intervention session. 
The intervention comprised of two components, high-load dynamic resistance 
exercises, and isometric exercises. During the intervention sessions participants 
were always closely supervised by the lead author. Participants were taught how to 
use the resistance machines and perform the exercises safely and with the correct 
technique. 
 
Heavy resistance exercise training 
Resistance exercises were based upon those previously performed in other high fall 
risk groups (23-26). Patients were asked to perform three series of up to twelve 
repetitions on three different machines; 1) a leg extension (extending the knee from 
90˚ to 0˚ flexion to lift the load and flexing to lower under control), 2) a leg press 
(extending the ankle, knee and hip from a flexed position [knee at >90˚] to a more 
extended position [knee ending close to full extension] and returning while lowering 
the load under control), and 3) an ankle press (plantar flexing the ankle from a dorsi 
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flexed angle and returning to lower the load under control). One repetition consisted 
of lifting and lowering the load under control in approximately 2 and 3 seconds, 
respectively. If the participant could perform three series of twelve repetitions or more 
in any one session, the load was increased for the subsequent week to maintain the 
training stimulus. If 36 (3 series of 12) repetitions could not be achieved, the load 
remained the same and the aim for the following week was to achieve more 
repetitions than the previous week, ultimately working towards three series of twelve 
repetitions for each load. Participants spent the first two weeks practicing the correct 
technique and becoming familiarised with the movements of the exercise by using 
relatively low loads, before progressing towards a suitable load required to yield 
improvements in strength.  
 
Isometric exercises 
With the primary aim of increasing the speed of muscle response of the ankle and 
knee flexors, ‘quasi-isometric’ exercises previously applied to improve SoSG in older 
adults (27) were performed on the same machines as those used for the heavy 
resistance exercises. Patients performed three series of twelve repetitions on two 
different machines. On the leg extension machine, the knee was fixed at 90˚ and for 
each repetition, participants attempted to rapidly extend the knee, activating the knee 
extensors as quickly as possible, but without knee joint movement due to the 
immovable load. On the leg press, the ankle was fixed at a neutral angle of 90˚ 
between the shank and foot and participants attempted to rapidly plantar flex the 
ankle, activating the ankle extensors as quickly as possible, but without movement of 
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the ankle joint due to the immovable load. The ankle and knee extensors were 
activated for half a second (in the respective exercises) followed by a one second 
rest in between repetitions. One-minute rest was given between series of twelve 
repetitions.  
 
Data analysis 
The reduction in numbers for this chapter and chapter 5 are the result of a number of 
factors. Participants were recruited from a large geographical area around 
Manchester, which meant that whilst it was possible for them to attend the initial two 
sessions, attending training sessions once a week for 16 weeks, as well as attending 
a further two testing session was infeasible. Furthermore, several participants were 
lost to injury, typically caused by gait problems related to neuropathy. 
 
Speed of strength generation during stair negotiation 
The SoSG at the ankle and knee was measured as the rate of joint torque 
development (RJTD). A joint torque is the rotational force around the joint, and can 
both cause and control of movement at the joint.  
 
Individual gait trials were labelled in Vicon Nexus software (Vicon, Oxford, UK) and 
then exported into Visual3D (C-Motion Inc, MD, USA) for further analysis. Joint 
torques were normalized to body mass to enable valid between-group and pre-post 
intervention comparisons. The RJTD of the landing leg was calculated from the 
gradient of the joint torque-time curve for the ankle and knee proceeding initial step 
Page | 86  
 
contact (9). In each stair trial, the joint torque values from each of the four step-
embedded plaforms were used and the mean taken, although in some trials not all 
four values were available (12% of values unavailable), so as many were used as 
possible. Due to problems with marker visibility and force platforms, two patients 
within the D-CON group, and one within the D-INT group were unable to provide 
accurate SoSG data (Data presented for SoSG: DPN-INT: n=6; D-INT: n=9; and D-
CON: n=4). 
 
Muscle activation during stair negotiation 
The muscle activation (electromyographic) signals were examined from the leg of the 
foot contacting the upper middle step of the eight-step staircase. Two stages of 
analysis were performed, the first stage identified when the activation of the muscle 
began and ended (defined as onset and cessation, respectively), and the second 
stage identified the peak of the muscle activity profile. In the first stage, the raw 
muscle activation signals were processed using a bespoke Matlab (Matlab v2008b, 
Mathworks, Natick, Massachusetts, USA) programme, as detailed previously (9, 22), 
which identified when muscles were ‘switched on and off’ (onset and cessation, 
respectively). The second stage identified muscle activation peaks of each muscle in 
Visual 3D, as described in detail previously (9). To enable accurate comparisons 
between groups, the commonly dominant peak was measured. The time to peak 
(TTP) was measured as the time difference between the onset of muscle activity and 
the peak of the muscle activation. Due to problems with obtaining muscle activation 
data (caused primarily by subcutaneous fat attenuating the muscle activation signal), 
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data could not be obtained for all participants, and only muscle activations of the 
patients who provided reliable data both pre and post-intervention were included in 
the results (DPN-INT: n=5; D-INT: n=9; and DCON: n=3).  
 
Statistics 
Pre- to post-intervention differences for all variables were tested using a repeated 
measures Student’s t-test. Pre- and post-intervention values in the diabetes groups 
(D-INT and DPN-INT) were tested for differences with respect to the H-CON group 
using a one-way analysis of variance (ANOVA) and Bonferroni post-hoc test. Values 
are presented as means ± SD; significance was set at p<0.05. 
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Results 
 
Speed of strength generation (Fig. 1 & 2) 
 
Stair ascent (Fig. 1) 
Ankle and knee SoSG were significantly higher post-intervention compared to pre-
intervention in the DPN-INT and D-INT groups (p<0.01). The D-CON group displayed 
no differences pre to post-intervention. 
 
Pre-intervention, the DPN-INT group displayed a similar ankle SoSG to the H-CON 
group; however, post-intervention, the DPN-INT group displayed a significantly faster 
SOSG than the H-CON group. Pre-intervention the D-INT group displayed a 
significantly slower ankle SoSG than the H-CON group. However, post-intervention, 
no differences between the D-INT and H-CON group were observed. Pre-
intervention, SoSG at the knee in both the D-INT and DPN-INT groups was 
significantly slower than the H-CON group. However, post-intervention, no 
differences between the diabetes groups and H-CON group were observed.  
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Figure 1. Ankle (ANK) and knee (KNEE) speed of strength generation (rate of joint 
torque development; RJTD) during stair ascent. Values are means and SD for 
healthy controls (H-CON; n=21), and pre- and post-intervention results for the 
diabetes intervention group (D-INT; n=9), diabetic peripheral neuropathy intervention 
group (DPN-INT; n=6), and the diabetic control group (D-CON; n=4). Pre-intervention 
values are displayed as the black bars, and improvements in SoSG post-intervention 
are displayed as the white bar on top (all post-intervention changes were increased 
compared to pre-intervention). * denotes significantly different SoSG pre- to post-
intervention (p<0.05).  
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Stair descent (Fig. 2) 
Ankle and knee SoSG were significantly higher post-intervention compared to pre-
intervention, in the DPN-INT and D-INT groups (p<0.01) and the D-CON group 
(p<0.05)  
 
Pre-intervention, SoSG at the ankle and knee in the D-INT group were significantly 
slower than the H-CON group, but no differences between the groups were observed 
post-intervention. Pre-intervention, the DPN-INT group displayed a similar SoSG at 
the ankle and knee to the H-CON group, but displayed a significantly higher SoSG 
than the H-CON group post-intervention. 
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Figure 2. Ankle (ANK) and knee (KNEE) speed of strength generation (rate of joint 
torque development; RJTD) during stair descent. Values are means and SD for 
healthy controls (H-CON, n=21), and pre- and post-intervention results for the 
diabetes intervention group (D-INT, n=9), diabetic peripheral neuropathy intervention 
group (DPN-INT, n=6), and the diabetic control group (D-CON, n=4). Pre-intervention 
values are displayed as the black bars, and improvements in SoSG post-intervention 
are displayed as the white bar on top (all post-intervention changes were increased 
compared to pre-intervention). * denotes significantly different SoSG pre- to post-
intervention (p<0.05). 
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Muscle activation timings (Fig. 3 & 4) 
 
Stair ascent (Fig. 3) 
The D-INT group activated the knee extensors significantly later, and displayed a 
slower TTP post-intervention compared to pre-intervention. The DPN-INT and D-
CON group activated the ankle extensors significantly later post-intervention 
compared to pre-intervention, but no other changes were observed.  
 
Stair Descent (Fig. 4) 
No changes in the onset of knee or ankle muscle activations were observed in any 
group. The D-INT and D-CON groups displayed a longer TTP in the knee extensors 
post-intervention compared to pre-intervention. Pre-intervention, the D-INT TTP of 
the knee extensors was significantly slower compared to the H-CON group, but no 
differences existed post-intervention. 
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Figure 3. Periods of activation for the knee extensor (KE; vastus lateralis) and ankle 
extensor (AE; medial gastrocnemius) muscles with respect to foot-step contact 
(occurring at time zero) during stair ascent. Values are means and SD for healthy 
controls (H-CON, n=21), and pre- and post-intervention results for the patients with 
diabetes but without neuropathy who underwent the intervention (D-INT, n=9), the 
patients with diabetic peripheral neuropathy who underwent the intervention (DPN-
INT, n=5), and the diabetic control group (D-CON, n=3). * denotes significantly 
different (p<0.05) timing between pre- and post-intervention results. Significance is 
shown for onset (asterisk before bar), time to peak (asterisk after the line within the 
bar), and duration timings (asterisk after bar). 
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Figure 4. Periods of activation for the knee extensor (KE; vastus lateralis) and ankle 
extensor (AE; medial gastrocnemius) muscles with respect to foot-step contact 
(occurring at time zero) during stair descent. Values are means and SD for healthy 
controls (H-CON, n=21), and pre- and post-intervention results for the patients with 
diabetes but without neuropathy who underwent the intervention (D-INT, n=9), the 
patients with diabetic peripheral neuropathy who underwent the intervention (DPN-
INT, n=5), and the diabetic control group (D-CON, n=3). * denotes significantly 
different (p<0.05) timing between pre- and post-intervention results. Significance is 
shown for onset (asterisk before bar), time to peak (asterisk after the line within the 
bar), and duration timings (asterisk after bar). 
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Discussion 
 
This study shows for the first time how a resistance exercise training intervention can 
improve the speed of ankle and knee strength generation during stair ascent and 
descent in patients with diabetes and particularly in patients with DPN. The increased 
SoSG of the ankle and knee are expected to improve stability during the initial weight 
acceptance phase of the stair walking tasks, and ultimately contribute towards 
reducing the risk of falling on stairs. Patients with diabetes, and particularly those with 
DPN, display a slower SoSG of the knee and ankle during stair negotiation when 
compared to healthy controls (9). The slower SoSG was suggested to compromise 
stability during stair walking, and is therefore likely to be an important contributory 
factor to the high incidence of falls in this population. A method by which SoSG can 
be increased is therefore of great importance for patients with diabetes and DPN, and 
the exercises performed in this study successfully improved characteristics indicative 
of reducing the risk of falling in patients with diabetes and DPN. 
 
Both diabetes intervention groups (D-INT and DPN-INT) displayed significantly faster 
ankle and knee SoSG post-intervention compared to pre-intervention, generating 
strength at the ankle and knee at speeds comparable to, and in some cases faster 
than, a healthy control group (H-CON group) following the intervention (Fig 1). The 
patients with DPN displayed larger improvements in SoSG as a result of the 
intervention compared to the diabetes group without neuropathy (D-INT) during both 
stair ascent and descent, increasing ankle and knee SoSG by 60% and 27%, 
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respectively during stair ascent (compared to 36% and 19% by the D group), and 
35% and 78% (compared to 12% and 24% by the D group) during stair descent, 
indicating that patients with diabetic neuropathy are highly responsive to resistance 
exercise training.  
 
During the weight acceptance phase of stair ascent and stair descent strength is 
rapidly generated to perform an absorptive action, controlling the flexion of the ankle 
and knee as gravity acts to ‘pull’ the body down onto the step. During stair descent 
the landing leg has to quickly stabilise before the trailing leg can move into the swing 
phase; whilst during ascent, the landing leg has to quickly stabilise the body before 
propelling it upwards. By generating joint strength quicker, the body is stabilised 
earlier into the stance phase allowing balance to be more optimally controlled. In the 
previous study (Chapter 2), I identified that the knee and ankle both 
performed ‘absorptive’ roles during ascent and descent, with one joint creating high 
levels of SoSG to primarily dissipate the ground impact and momentum, whilst the 
other joint contributed to absorption to a lesser extent and later in the stance phase  
(9). The DPN-INT group improved the SoSG of the primary ‘absorptive’ joint by 27% 
and 35% (the knee during ascent, and the ankle during descent, respectively), whilst 
the secondary ‘absorptive’ joint improved by 60% and 78% (the ankle during ascent, 
and the knee during descent). This may indicate an altered distribution of ground 
impact absorption, with the secondary absorptive joint playing a relatively greater role 
post-intervention in supporting and stabilising the body. Furthermore, despite DPN 
being predominantly a distal disease, similar improvements were observed at the 
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ankle during stair ascent and descent (35% and 60% respectively) as were observed 
at the knee during stair descent and ascent (27% and 78% respectively). This 
highlights that even distal muscles can still be markedly improved by resistance 
exercise training in patients with DPN. 
 
Muscle activations were altered as a result of the intervention (Fig 2 & 3), but no clear 
patterns emerged which may explain the increase in SoSG (Fig. 1). Despite SoSG 
increasing significantly at both joints during stair ascent and descent, the TTP, 
previously suggested to be closely related to SoSG, varied between groups (slower 
TTP of the knee extensors in the D-INT and DPN-INT groups during stair descent, 
and quicker TTP of the knee extensors during ascent) and showed no changes in 
line with the increases in SoSG that were observed previously (Fig 2 & 3)(9). An 
increase in muscle strength as a result of the exercise intervention may therefore be 
the main causative factor for the faster SoSG observed at the ankle and knee, rather 
than increased speed of muscular activations. Whilst the TTP was unaltered by the 
intervention, if maximum joint moments were increased, and the time to reach this 
maximum was unaltered (as indicated by the unaltered TTP), the speed of strength 
generation would be faster, as was indeed observed. This would indicate that the 
improvement in strength as a result of the resistance exercise intervention performed 
may be the most influential factor upon improving SoSG rather than improving the 
speed of muscle response. 
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Reduced SoSG in other high-risk populations such as the elderly has been attributed 
to structural alterations to the muscle and neural changes (20, 29). Resistance 
exercise training has been identified to be the most effective method of increasing 
SoSG via improving neural drive and increasing muscle mass, consequently 
increasing SoSG during dynamic movements and during isolated strength tests (19, 
20, 30, 31). In this sample of patients, the muscular adaptations are expected to be 
more influential than neural adaptations, with the improvements in SoSG observed in 
patients with diabetes and DPN expected to be predominantly caused by 
improvements in muscle strength rather than changes in speeds of muscle activation 
(29). This is a particularly pertinent finding as it may partly explain how patients with 
DPN can improve SoSG despite presumably irreversible neural damage. 
 
Exercise interventions with the specific aim to improve SoSG in an elderly population 
have previously been suggested to be more effective at reducing the risk of falling 
than more generalised exercises (6), yet such studies had not previously been 
performed in a diabetic patient population. The present study has shown that 
resistance exercises are an effective way of increasing ankle and knee SoSG, which 
may translate to improvements in balance and safety during stair ascent and 
descent. Such exercises should therefore be incorporated into multi-faceted exercise 
interventions to improve safety in people with diabetes and DPN.   
 
In terms of the clinical and practical implications of the intervention, the exercise 
session was performed by the patients just once a week and took less than one hour. 
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The intervention also fitted around the patient’s lives, accommodating patients if they 
missed a session, although patients were required to attend a minimum of 10 of the 
16 sessions, and to not miss more than two weeks in a row to be included in the pre-
post results (participants attended ~80% of the sessions on average). Patients who 
missed one or two sessions displayed no decreases in strength for the following 
week (in terms of training load and number of repetitions performed), raising the 
possibility that lower limb strength levels may be maintained if the frequency of 
exercise is reduced to less than once a week. Patients self-reported increased 
activity levels, and an ability to perform everyday tasks that were previously beyond 
their capabilities as a result of the increased lower limb strength following the 
resistance exercise intervention. These self-reported observations should be taken 
with caution against the main scientific findings, but are in line with previous findings 
of increased six minute walking distance and daily step counts as a result of exercise 
(18). The present findings suggest that one hour of resistance exercise training per 
week may be an effective method of improving factors contributing to the risk of 
falling and may therefore translate to reducing fall risk in patients with diabetes and 
DPN.  
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Chapter 4 
 
Observed, or unobserved, those are the tripping hazards: Patients 
with diabetic peripheral neuropathy display a decreased stepping 
accuracy and increased toe clearance during walking 
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Abstract 
 
Aims: Patients with diabetic peripheral neuropathy (DPN) are five times more likely 
to fall than age-matched controls, and approximately 50% of all falls are due to 
tripping whilst walking. This study examines characteristics of patients with DPN that 
may be indicative of the potential for tripping on observed and unobserved hazards. 
 
Methods: Sixty two participants; 19 patients with DPN, 22 patients with diabetes but 
no neuropathy (D) and 21 healthy non-diabetic control participants (C) performed two 
tests. Accuracy of stepping and visual gaze parameters were measured as 
participants negotiated a walkway with stepping targets, and minimum toe clearance 
was measured during level ground walking. 
 
Results: Patients with diabetes and DPN were significantly less accurate at stepping 
on targets than control participants, and displayed a higher minimum toe clearance 
during level ground walking (p<0.05). Patients with DPN also displayed an altered 
visual gaze strategy to control participants, however these findings are made from 
preliminary data from a small cohort of the participants (DPN: 4; D: 4; C: 4). 
 
Conclusions: Patients with DPN display characteristics that indicate they are more 
likely to trip on observed obstacles than unobserved obstacles. A reduced stepping 
accuracy may lead to patients with DPN being less able to avoid observed obstacles 
during walking, whilst an increased toe clearance is expected to be a compensatory 
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mechanism to avoid obstacles. Visual gaze characteristics indicated an altered visual 
strategy in patients with DPN compared to controls during stepping, which together 
with impaired motor control may underlie the changes in stepping accuracy. 
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Introduction 
 
Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, 
characterised by sensory loss in the lower limbs, altered joint-position sensation and 
impaired muscular function, which can result in alterations to gait (1-4). Patients with 
DPN are five times more likely to fall than age-matched controls, and approximately 
50% of all falls are due to tripping whilst walking (5, 6). It has been suggested that the 
incidence of trip related falls is determined primarily by the frequency of tripping, and 
not the ability to recover from a trip (7). Therefore, the most effective approach to 
identifying the risk of falling for a particular individual or population is to examine their 
ability to avoid obstacles before they become a tripping hazard (8, 9). Tripping can 
occur as a result of observed and unobserved hazards. When a tripping hazard is 
observed, the person must initiate and co-ordinate a response to avoid it. However, 
during level ground walking, some hazards such as an uneven surface may not be 
observed, and therefore fundamental characteristics of gait may increase or 
decrease the potential for tripping. 
 
People with a high risk of falling have been shown to be less accurate and more 
variable at stepping onto defined targets (10, 11). This reduced ability to move the 
foot where desired may indicate an impaired control of foot trajectory, which could 
hinder obstacle avoidance, and ultimately increase the probability of tripping on 
observed hazards (8). Causes for a decreased accuracy of stepping are expected to 
be multi-faceted, with altered motor control and visual gaze strategies expected to be 
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contributory factors. Whilst visual gaze strategy has not to my knowledge been 
evaluated in people with diabetes, it is known that people with a high risk of falling, 
such as the elderly population, display differing visual gaze strategies to lower risk 
groups, altering where and when they look during walking (10-12). Previous studies 
have theorised that visual gaze strategy alters stepping accuracy through taking 
attention away from the combined positions of the feet and intended targets, but no 
universal agreement on the exact mechanisms currently exist (10, 11). 
 
Whilst responses can be co-ordinated to avoid observed tripping hazards, the 
potential for tripping on unobserved hazards are dependent upon characteristics of 
normal gait. Minimum toe clearance is the minimum height of the toes above the 
ground during the mid-swing phase of gait, and is a particularly dangerous event due 
to the low ground clearance and high velocity of the swinging limb during this phase 
of gait (8). Because of this, minimum toe clearance has been reported as a potential 
indicator for the risk of tripping and consequential falling during walking in the elderly 
population (9, 13, 14). The stride-to-stride variability of minimum toe clearance has 
also been suggested as one of the most important indicators of tripping potential 
(14). Elderly participants for example, display similar average toe clearances to 
younger participants, but show an increased variability, which may be one of the 
major factors explaining an increased risk of falling in the elderly population (14). If 
patients display a smaller and more variable minimum toe clearance, this may 
therefore lead to an increased risk of tripping on unobserved hazards. 
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The aim of this study was to investigate the effects of DPN on stepping accuracy and 
minimum toe clearance during level ground walking. Furthermore, this study aimed to 
provide pilot observations of between-group differences in underlying visual gaze 
strategies, which may affect stepping accuracy. It was hypothesised that patients with 
DPN would display similar characteristics to other populations at a high risk of falling, 
displaying a decreased accuracy of stepping, and a lower and more variable 
minimum toe clearance. Furthermore, patients with DPN were expected to display an 
altered visual gaze strategy. 
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Methods 
 
Participants 
Sixty two participants; 19 patients with DPN, 22 patients with diabetes but no 
neuropathy (D) and 21 healthy non-diabetic control participants (C) matched for age 
and BMI (Table 1) gave their written informed consent to participate in this study, 
which was given ethical approval from the relevant bodies. Major exclusion criteria 
were open ulcers, use of walking aids, a history of other disorders affecting gait and a 
visual acuity <6/18 (of any aetiology, including diabetic retinopathy). 
 
Neuropathy assessment & classification 
The presence and severity of neuropathy was measured using two separate tests: 
the Modified Neuropathy Disability Score (mNDS)(1, 2), and the Vibration Perception 
Threshold (VPT)(1, 2) using a neurothesiometer (Horwell, Nottingham UK). Patients 
were deemed to have moderate to severe neuropathy and grouped as DPN if in 
either one or both of their feet they displayed either an mNDS score of ≥6, or a VPT 
of ≥25 Volts (or both). Patients were deemed to have no neuropathy and were 
grouped as D, if in both feet they displayed scores for the mNDS of ≤5 and for the 
VPT of ≤24 Volts (1, 2)(Table 1). 
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Table 1. Participant demographics, neuropathy scores and temporal gait 
characteristics for the control (C), diabetes (D) and diabetic peripheral neuropathy 
(DPN) groups. Values are means ± SD. * denotes significantly different to the control 
group. Gait velocity was taken during level ground walking. Stance times were taken 
during the stepping accuracy task, and display results for the whole cohort of 
participants (a), and the subset that provided visual gaze data (b). 
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Procedure  
Preparation 
Sixteen retro-reflective markers were attached to the participant’s feet (8 on each 
foot) according to standard motion analysis preparation methods. Three dimensional 
marker positions during both walking tests described below (stepping accuracy task 
and level ground walking) were recorded by a ten-camera motion capture system 
recording at 120Hz (Vicon Nexus, Vicon, Oxford, UK). Footwear was standardised 
across all participants (MedSurg, Darco, Raisting, Germany). 
 
Stepping accuracy task 
Participants were asked to walk along a 7m long mat with stepping targets as 
previously described (15)(Fig. 1) until five trials were captured. Each participant was 
given the same instructions: “walk at your natural walking speed, stepping on each of 
the targets as accurately as possible.” Participants performed five trials of which 
three were used for analysis. Kinematic data of foot position, and analogue data of 
horizontal eye movement were captured from the middle six stepping targets (R4, L4, 
R5, L5, R6, L6) from a total of eighteen (Fig. 1)(15). Visual gaze direction was 
obtained using an eye-tracking scanner (ASL 500 mobile gaze tracking system, 
Bedford, MA, USA) with a sampling frequency of 50Hz, which used corneal and pupil 
reflections to calculate eye in orbit rotation to an accuracy of one degree. 
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Figure 1. Diagram of the stepping walkway used for the stepping accuracy task. 
Targets are numbered in order of contact; with ‘L’ denoting left foot contact and ‘R’ 
denoting right foot contact. 
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Level ground walking 
Participants were asked to walk freely (without any stepping targets) at their natural 
speed along an 8m long walkway until five trials were captured. The middle four 
strides (two lefts and two rights) were captured. The trajectory of the 2nd Toe marker 
(placed on the nail of the second phalange of both feet) was captured, and the 
movement in the vertical axis used for analysis. 
 
Data analysis 
Foot stepping accuracy 
Thirty six (C: 10; D: 12; and DPN: 14) participants performed the stepping accuracy 
task. Stepping accuracy was calculated as the difference between the position of the 
distal aspect of the 2nd metatarsal head (2MH), with respect to the calibrated centre 
of the targets, at foot-ground contact (measured using the tracked marker 
coordinates from the motion analysis and the known position of stepping targets 
within the capture volume). Foot-ground contact was calculated manually as the point 
at which the trace of the vertical position of the foot reached a fixed minimum height. 
The co-ordinates of the 2MH at foot-ground contact (medio-lateral: x and anterior-
posterior: y) were subtracted from the co-ordinates of the calibrated target positions 
to calculate the distance of the 2MH from the target. Using the square root of the two 
squared distances (x and y), the hypotenuse of the triangle, the absolute distance 
between the target and the 2MH, was calculated.     
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Visual acquisition parameters 
Data from twelve participants (C: 4; D: 4; and DPN: 4 [216 saccades analyzed in 
total: 18 saccades per participant]) were used for analysis of visual acquisition. Data 
were obtained from a sub-sample of the cohort due to the time-consuming nature of 
these measurements precluding assessment in all participants; non-spherical corneal 
shape as the result of surgery in some participants and eyelashes covering the eyes 
during the tests. Because of the small cohort of participants, the results are 
presented as preliminary pilot data.  
 
Two points in the horizontal signal of the eye movement trace were identified: the 
initial visual acquisition of the target (start of visual acquisition), and the point at 
which gaze was subsequently directed away from the target (visual acquisition end). 
These events were identified using the second derivative of the eye position signal, 
i.e. the eye acceleration peak at saccade onset. By using the timing of when each 
individual target was visually acquired, and when gaze was subsequently directed 
away, four separate variables were obtained: the time between visual acquisition of 
the target and foot-target contact; the time between the subsequent saccade away 
from the target with respect to foot-target contact; the time spent looking at the target 
(fixation duration); and the time taken to transfer gaze between targets.  
 
Minimum toe clearance 
Fifty nine (C: 18; D: 22; and DPN: 19) participants performed the level walking task to 
obtain minimum toe clearances. Using a bespoke script in Visual3D motion analysis 
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software (C-Motion Inc, MD, USA), the minimum toe clearance of the second toe was 
calculated as the lowest point occurring during the swing phase in the trace of the 
second toe in the vertical axis (9). One minimum toe clearance value was taken from 
each of the three trials, per participant.  
 
Statistics 
Group differences were tested using a one-way analysis of variance (ANOVA) with a 
Bonferroni post-hoc test, and all significances reported with respect to the control 
group. Values are presented as means ± SD; significance was set at p<0.05. The 
level of agreement between stance time during the stepping task and visual gaze 
cycle time was tested using a Pearson’s correlation.  
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Results 
 
Stepping accuracy (Fig. 2) 
Patients with diabetes (both D and DPN groups) were less accurate at stepping, and 
contacted the ground significantly further away from the centre of the target than the 
C group.   
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Figure 2. Group differences in stepping accuracy for controls (C; n=10), patients with 
diabetes but no neuropathy (D; n=12), and patients with diabetic peripheral 
neuropathy (DPN; n=14). The black inner circle denotes the mean distance from the 
centre of the target (0), and the white outer circle denotes the standard deviation. * 
denotes significantly different group mean accuracy compared to the control group 
(p<0.05). 
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Visual acquisition parameters (Fig. 3a & 3b) 
In absolute time, patients with DPN visually acquired the targets significantly later, 
remained looking at the targets until significantly later, and spent significantly less 
time in total looking at the targets than a control population. The DPN patients also 
took significantly longer to look between one target and the next. The D group 
acquired targets significantly later than the control group, but no other changes were 
observed (Fig. 3a). 
 
Markedly different stance times were observed in the cohort providing visual gaze 
data (Table 1; stance time (b)), and it was anticipated this may impact on the 
interpretation of visual gaze results presented in absolute time. Visual cycle duration 
correlated very highly with stance time of these participants (r = 0.99; Table 1.). 
Therefore, the results have also been presented as a percentage of the visual gaze 
cycle, to elucidate the visual gaze strategy independent of differences in stance time. 
 
When presented as a percentage of the visual gaze cycle, patients with DPN visually 
acquired the targets significantly later, and remained looking at the targets until 
significantly later compared to the control group. The D group also looked away from 
targets significantly later than the control group, and both D and DPN groups spent 
significantly less time looking at the target and took significantly longer to look 
between targets (p<0.05) compared to healthy controls (Fig. 3b). 
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Figure 3. Target visual acquisition parameters during the stepping task for controls 
(C; n=4), patients with diabetes but no neuropathy (D; n=4), and patients with 
diabetic peripheral neuropathy (DPN; n=4). Values are means and standard 
deviations. 3a displays the results in absolute time and 3b displays the results as a 
percentage of the entire visual gaze cycle. The black bars denote visual fixation of 
the target, and the white bars denote the time looking between targets, with the end 
of the white bar denoting the acquisition of the next target. * denotes significantly 
different compared to control group (p<0.05). 
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Minimum toe clearance (Fig. 4) 
Patients with diabetes, both with and without neuropathy, displayed a significantly 
higher minimum toe clearance than the control population during walking. No 
significant differences in the intra-participant variability of minimum toe clearance 
were observed between groups. 
 
The minimum toe clearance values may be considered relatively high, but it should 
be noted that the values presented here include the addition of the toe depth and 
shoe bed (which is thick by standard shoe dimensions). These factors have therefore 
contributed to yielding higher toe clearance values than if the participant was 
barefoot. 
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Figure 4. Minimum toe clearance height for controls (C; n=18), patients with diabetes 
but no neuropathy (D; n=22), and patients with diabetic peripheral neuropathy (DPN; 
n=19). Values are means and standard deviations. * denotes significantly different 
compared to control group (p<0.05). 
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Discussion 
 
Patients with diabetes and diabetic peripheral neuropathy (DPN) display gait 
characteristics that may be indicative of a reduced ability to avoid observed 
obstacles, but may reduce the risk of tripping on unobserved obstacles. Therefore, 
larger, more observable, obstacles may be a greater risk to patients with DPN than 
smaller, less observable hazards such as subtle changes in flooring. 
 
Patients with diabetes and DPN were less accurate at stepping, which may indicate 
an impaired ability to avoid any potential upcoming obstacles during walking. These 
preliminary data indicated an altered visual gaze strategy in patients with DPN, which 
along with impaired motor control, may be an underlying reason for the decreased 
stepping accuracy. Patients with diabetes without neuropathy also displayed an 
altered visual gaze strategy, although to a lesser extent than in patients with DPN. 
This may indicate early adaptations of altered visual gaze and motor control 
strategies before peripheral neuropathy can be quantified using standard clinical 
assessments. During level ground walking, patients with DPN displayed higher 
minimum toe clearances, whilst displaying a similar intra-participant variability to 
control participants (Fig. 4). An increased minimum toe clearance may in fact be 
regarded as a safer gait pattern in DPN patients, and is likely a compensatory 
strategy to lift the toes above any unobserved tripping hazards when walking, 
therefore reducing the risk of tripping. Although differences in the visual gaze strategy 
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were clearly evident between groups, these data are considered as preliminary 
findings due to the small cohorts for this parameter.  
 
The reasons for the decreased stepping accuracy observed in patients with DPN are 
expected to be multi-faceted, with reduced motor control and altered visual gaze 
patterns expected to be major contributory factors. The reasons for decreased 
stepping accuracy in other high fall risk groups have been typically explained by 
altered visual gaze patterns. Yamada et al. identified that the elderly patients’ fixation 
on imminent targets hindered their ability to plan footfall for future targets (10), whilst 
conversely, Chapman & Hollands concluded that the planning of future movements 
affected the accuracy of ongoing movements (11). In the present study, patients with 
DPN displayed a ‘hesitant’ visual gaze strategy, by continuing to look at targets until 
after foot-target contact, before re-directing gaze to the next target, possibly in an 
attempt to ensure foot-target contact (Fig 3a & 3b)(16). This contrasts with the 
‘confident’ visual gaze strategy observed in the C group, who re-directed gaze away 
to the next target immediately upon foot-step contact, indicating a confidence in their 
ability to step accurately. Patients with DPN also displayed an increased time interval 
to look between targets. The combination of looking away from the target later, and 
taking longer to look between targets, may therefore explain why patients with DPN 
are slower to initially visually acquire the target, resulting in a decreased total time 
spent looking at the target. The decreased time available to look at the target during 
the approach may have hindered co-ordination of an appropriate motor response, 
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contributing to altered swing trajectories of the lower limbs, and ultimately resulting in 
a reduced stepping accuracy.   
 
Diabetic controls were even slightly less accurate at stepping than patients with DPN, 
which is suggested to be due to a less effective specific aspect of the visual gaze 
strategy than DPN patients. This visual gaze strategy in diabetic controls (looking 
away from the target sooner after foot-target contact than DPN patients) could 
perhaps be regarded as an ‘over-confident’ strategy that seems to have adversely 
affected their stepping accuracy, since this was significantly worse than in healthy 
controls, and even slightly less accurate than DPN patients. This may further indicate 
that diabetic controls displayed some of the altered motor control characteristics of 
patients with DPN before sensory neuropathy is clinically observed, and before this 
population are aware of their decreased ability to control trajectory of the swinging 
leg. The combination of an ‘over-confident’ visual gaze strategy and altered motor 
control of the lower limbs may therefore explain the poor accuracy of stepping in this 
diabetic control population.  
 
Impaired lower limb motor control, likely caused by neural and muscular alterations is 
also expected to contribute to the reduced stepping accuracy observed in both 
diabetes groups. Patients with DPN display a reduced nerve conduction velocity, 
reducing the speed at which movements can be co-ordinated and performed (17, 18). 
Furthermore, they have a reduced range of movement, decreased strength, and a 
decreased ability to rapidly develop strength when required (19-21). Whilst these 
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factors have been observed to affect certain gait characteristics (stride length, 
cadence and velocity), it is expected that these mechanisms are also important 
factors for lower limb motor control. The combination of impaired motor control and 
altered visual gaze strategy are expected to be major factors in reducing stepping 
accuracy in patients with diabetes, and particularly DPN.  
 
In contrast to the initial hypothesis, patients with DPN displayed larger toe clearances 
than controls during walking (Fig. 4). When people from the general population are 
unsure of foot position, such as when carrying a laundry basket, gait velocity is 
reduced, stride width is increased, and toe clearances are increased (22). 
Furthermore, when obstacles are present, but not observable, minimum toe 
clearance has been shown to increase (23). Patients with DPN may therefore employ 
larger toe clearances as a compensatory mechanism, anticipating potential upcoming 
obstacles that they may not visually identify. Further explanations may be a flatter 
trajectory of the foot during gait (i.e., foot remains more parallel to the ground), due to 
the hip-strategy commonly employed by patients with neuropathy, and the smaller 
range of movement observed at the knee and ankle joints (24-26). This ‘natural 
strategy’ may in fact be the safest for DPN patients, allowing a greater chance of 
avoiding a low tripping obstacle. Variability of toe clearances has been identified as a 
predominant indicator of tripping potential (14). Patients with DPN however displayed 
similar intra-participant variability of toe clearances during walking. Therefore, the 
primary causative factor for tripping during level ground walking may be the 
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combination of altered visual gaze and motor control strategies rather than an 
increased variability in toe clearances. 
 
To reduce the potential for tripping in patients with diabetes and DPN, an intervention 
that aims to modify visual gaze strategy and motor control may improve the ability to 
observe upcoming obstacles and increase the accuracy of stepping. Previous studies 
in other (non-diabetic) populations have shown that balance can be improved and 
visual gaze strategy can be altered using such training, which could improve safety 
(15, 27). Furthermore, a resistance exercise training-based element may improve 
control of the foot and ankle during walking, and improve avoidance of any tripping 
hazards. 
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Chapter 5 
 
Walk this way: Effects of resistance exercise and visual gaze 
training on stepping accuracy in patients with diabetic peripheral 
neuropathy - implications for the risk of trip-related falls 
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Abstract 
 
Introduction: Patients with diabetes and diabetic peripheral neuropathy (DPN) are 
less accurate at stepping than age-matched controls, which may hinder their ability to 
avoid potential tripping hazards. This study examines the effects of a multi-faceted 
exercise intervention on stepping accuracy in patients with diabetes and DPN. 
   
Methods: Forty participants; 10 patients with DPN, 20 patients with diabetes but no 
neuropathy (D) and 10 healthy controls (H-CON) took part in the study. Accuracy of 
stepping was measured pre- and post-intervention as participants walked along an 
irregularly arranged stepping walkway. Participants in the intervention group attended 
a one-hour session, once a week, for sixteen weeks, involving high-load resistance 
exercise and visual-motor training. 
  
Results: Patients who took part in the intervention significantly improved stepping 
accuracy (p<0.05). The diabetic control group did not display any significant 
differences in stepping accuracy pre- to post- the intervention period. 
 
Discussion: The improved stepping accuracy observed in patients with diabetes and 
DPN as a result of the intervention is expected to translate to an improved ability to 
co-ordinate the appropriate response to avoid a potential tripping hazard. The 
improvements in stepping accuracy are expected to be the result of improvements in 
motor control and visual gaze strategy. A multi-faceted intervention such as the one 
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performed in this study could be incorporated into a clinical treatment programme to 
improve the general health and safety of patients with diabetes. 
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Introduction 
 
Patients with diabetic peripheral neuropathy (DPN) are five times more likely to fall 
than age-matched controls, and approximately fifty percent of all falls are due to 
tripping whilst walking (1,2). Falling can result in serious injury, and in extreme cases 
even death (3,4). Further to the physical consequences of falling, is the considerable 
economic burden to national health bodies. Therefore, a means by which the number 
of falls in this population can be reduced is of great interest, not only to patients with 
DPN, but also to national health authorities, employers and the general population.  
  
The frequency of tripping has been shown to be a major contributory factor to the 
probability of falling (5,6). Therefore, if the frequency of tripping can be reduced, then 
theoretically, so will the risk of falling. A key approach to reducing the risk of tripping 
is to improve a patient’s ability to avoid obstacles before they become a tripping 
hazard. In the previous chapter I investigated two different aspects of gait in diabetes 
patients, which were suggested to relate to the risk of tripping on observed and 
unobserved obstacles (Chapter 4). Whilst it was found that patients with DPN 
displayed an increased minimum toe clearance, which would reduce the risk of 
tripping on smaller, unobserved hazards; stepping accuracy was decreased, which is 
indicative of a reduced ability to avoid observed obstacles. This impaired ability to 
move the foot where desired is thought to be caused by decreased motor control of 
the lower limbs and an altered visual gaze strategy. Therefore it was hypothesised 
that if the motor control and visual gaze strategies can be altered to resemble those 
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employed by the non-diabetic healthy population, stepping accuracy may therefore 
be consequently improved. 
 
Resistance training to increase lower limb muscle strength is expected to improve 
motor control, and therefore increase the accuracy of stepping (6-10). Previous 
studies in diabetes patients have shown that resistance and balance training can 
improve gait speed, muscle strength, postural sway, joint strength and activity levels 
(11-13), but no studies have yet looked at the effects on stepping accuracy in 
diabetes patients. Furthermore, patients with cerebellar and vestibular dysfunction 
and healthy young adults have displayed improvements in gait velocity, postural 
stability and stepping accuracy in response to visual gaze-based training (14-16). 
Therefore, it is hypothesised that the combination of such training programmes 
(resistance exercise and visual gaze training) may be beneficial for stepping 
accuracy in patients with DPN. This study therefore examines the effects of a multi-
factorial intervention on stepping accuracy in patients with diabetes, both with and 
without DPN. Resistance-based exercises were performed to increase ankle and 
knee extensor strength, with the aim to improve motor control of the lower limbs and 
consequently improving the accuracy of foot swing trajectories during stepping. 
Visual gaze exercises were performed with the aim to alter visual gaze strategy, 
teaching patients to visually plan their stepping route before walking, with the aim to 
encourage patients to use vision more for ‘feedforward’ planning, as well as their 
current use for ‘feedback’ of foot position (6). It is hypothesised that such exercises 
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will improve the use of vision during walking, and motor control of the lower limbs, 
leading to an increased stepping accuracy.  
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Methods 
 
Participants 
Forty participants: 10 patients with DPN (Age: 56.8 ± 9.6 years; and BMI: 28.9 ± 4.6 
kg.m-1; mean ± SD), 20 patients with diabetes but no neuropathy [D](Age: 58.9 ± 11.7 
years; and BMI: 27.2 ± 3.8 kg.m-1) and 10 healthy controls [H-CON](Age: 66.3 ± 11.5 
years; and BMI: 25.1 ± 3.1 kg.m-1) gave their written informed consent to participate 
in this study, which was given ethical approval from the relevant bodies. A healthy 
control group was included to provide a reference condition, displaying ‘optimal’ 
performance, providing a comparison to pre- and post-intervention characteristics of 
patients with diabetes. Patients were excluded if they had open ulcers, required the 
use of a walking aid, had a history of other disorders affecting gait, or a visual acuity 
of <6/18 (of any aetiology). 
  
Neuropathy assessment & classification 
The presence and severity of neuropathy was measured using two separate tests: 
the modified Neuropathy Disability Score (mNDS) (17,18), and the Vibration 
Perception Threshold (VPT) (17,18) using a neurothesiometer (Horwell, Nottingham 
UK). Patients were deemed to have moderate to severe neuropathy, and grouped as 
DPN if in either one or both of their feet they displayed either an mNDS score of ≥6, 
or a VPT of ≥25 (or both). Patients were deemed to have no neuropathy and were 
grouped as D, if in both feet they displayed scores for the mNDS of ≤5 and for the 
VPT of ≤24 (17,18). 
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Pre- and post-testing procedures  
Sixteen retro-reflective markers were attached to the participant’s feet (8 on each 
foot) according to standard motion analysis preparation methods. Three-dimensional 
marker positions were then tracked during the stepping accuracy task described 
below, by a ten-camera motion capture system recording at 120Hz (Vicon Nexus, 
Vicon, Oxford, UK). All participants wore specialist diabetic shoes (MedSurg, Darco, 
Raisting, Germany) with a neutral foot-bed, to standardise footwear between groups, 
and to ensure that the diabetic patients walked with appropriate footwear.  
 
Participants were asked to walk along a 7m long mat with stepping targets designed 
to specifications previously described by Marple-Horvat & Crowdy (19)(Fig. 1) until 
five trials were captured. Each participant was given the same instructions: “walk at 
your natural walking speed, stepping on each of the targets as accurately as 
possible.” Participants performed five trials of which three were used for analysis. 
Kinematic data of foot position were captured from the middle six stepping targets 
from a total of eighteen (R4, L4, R5, L5, R6, L6)(19)(Fig. 1). 
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Figure 1. Diagram of the stepping walkway used for the stepping accuracy task. 
Targets are numbered in order of contact; with ‘L’ denoting left foot contact and ‘R’ 
denoting right foot contact. 
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Multi-factorial intervention 
Diabetes patients were randomly allocated into either the intervention group or a 
control group (who did not take part in the resistance exercise training) using a 
random number generator, with an expected weighting of 2:1 into the intervention 
and control groups, respectively. Twenty four participants were allocated into the 
intervention group (D-INT, n=17; and DPN-INT, n=7), and seven (D: n=4; DPN: n=3) 
were allocated into the control group. Due to the relatively small number of patients 
within the diabetes control group, data from D and DPN patients were grouped 
together and presented as a single diabetic control group (D-CON; n=7). Sample size 
was considered sufficient to analyse the intervention group data separately as D and 
DPN groups (D-INT and DPN-INT). To determine the adequacy of the group samples 
in the present study, the statistical power to detect pre-to-post intervention 
differences in stepping accuracy were tested for the DPN-INT group post-hoc (n=7). 
The statistical power was found to be 0.81, indicating the study was well powered to 
identify true differences with these specific parameters. 
 
Patients in the intervention group attended a weekly, one-hour session, at a private 
gym within the research institute (used for research purposes only), for a 16-week 
period. Within this session, a series of resistance training exercises and visual gaze 
training strategies were performed (see relevant sections below for further details) 
with the aim to improve the visual and motor limitations previously observed in 
patients with diabetes and DPN (Chapter 4). During the intervention sessions, 
participants wore un-restrictive clothes and their own footwear. After the 16-week 
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intervention period, patients in both control and intervention groups repeated the 
stepping accuracy task as described above. The post-intervention test took place 
within one month of the last intervention session.  
 
Visual gaze and motor control training 
A visual gaze and motor control training task was performed in which participants 
negotiated a small stepping walkway, comprised of six stepping targets. The 
arrangement of these stepping targets was randomised each week to avoid any 
learning of the stepping pattern, but was in principal similar to the stepping walkway 
used pre- and post-testing described above (irregularly placed targets, with steps of 
different lengths). Patients walked in both directions on the walkway used during the 
intervention, to reduce any learning effects of the stepping pattern. Before 
participants began each walkway negotiation and while standing at the start, they 
were instructed to trace their upcoming walk with their eyes three times before they 
actually walked through the stepping task. This was performed in an effort to improve 
visual gaze strategy by encouraging patients to look at targets in advance of stepping 
onto them, promoting optimal use of a ‘feedforward’ strategy of visually planning their 
route. The stepping task (with the necessary visual trace) and walk were performed 
five times in each direction.  
 
Resistance exercise training 
Resistance exercise training sessions were always closely supervised by the lead 
researcher. Participants were taught how to use the resistance machines and 
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perform the exercises safely and with the correct technique. Participants spent the 
first two weeks practicing the correct technique and becoming familiarised with the 
movements of the exercise by using relatively low loads, before progressing towards 
a suitable load required to yield improvements in strength. In the first session 
following the initial two-week period, patients gradually increased the load until it was 
sufficiently challenging to perform no more than ten repetitions. One repetition 
consisted of lifting and lowering the load under control in approximately 2 and 3 
seconds, respectively. In the following fourteen weeks, patients were asked to 
perform three sets of up to twelve repetitions on three different machines; a leg 
extension (extending the knee from 90˚ to 0˚ flexion to lift the load and flexing to 
lower under control), a leg press (extending the ankle, knee and hip from a flexed 
position [knee at >90˚] to a more extended position [knee ending close to full 
extension] and returning while lowering the load under control), and an ankle press 
(plantar flexing the ankle from a dorsi flexed angle and returning to lower the load 
under control). If the participants could perform three sets of twelve repetitions or 
more in any one session, the load was increased for the subsequent week to 
maintain the training stimulus. If 36 (3 x 12) repetitions could not be achieved, the 
load remained the same and the aim for the following week was to achieve more 
repetitions than the previous week, ultimately working towards three times twelve 
repetitions for each load.  
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Data analysis 
Foot stepping accuracy 
Twenty nine participants (DPN-INT: 5 [mean ± SD age: 58.8 ± 10.2 years; BMI: 26.8 
± 2.9 kg.m-1]; D-INT: 8 [age: 63.4 ± 9.8 years; BMI: 29.4 ± 3.2 kg.m-1]; D-CON: 6 
[age: 54.5 ± 7.8 years; BMI: 28.2 ± 5.6 kg.m-1] and H-CON: 10 [age: 66.3 ± 11.5 
years; BMI: 25.1 ± 3.1 kg.m-1]) performed the stepping accuracy task, pre- and post-
intervention. Eleven participants from the intervention groups (D: 9; and DPN: 2) 
were tested pre-intervention but withdrew from the process during the intervention 
period because of reasons unrelated to the study. Stepping accuracy was calculated 
as the difference between the position of the distal aspect of the 2nd metatarsal head 
(2MH), with respect to the calibrated centre of the targets, at foot-ground contact 
(measured using the tracked marker coordinates from the motion analysis and the 
known position of stepping targets within the capture volume). Foot-ground contact 
was calculated manually as the point at which the trace of the vertical position of the 
foot reached a fixed minimum height. The co-ordinates of the 2MH at foot-ground 
contact (medio-lateral: x and anterior-posterior: y) were subtracted from the co-
ordinates of the calibrated target positions to calculate the distance of the 2MH from 
the target. Using the square root of the two squared distances (x and y), the 
hypotenuse of the triangle, the absolute distance between the target and the 2MH, 
was calculated.     
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Statistics 
All statistical tests were performed on SPSS statistical package (SPSS v18, Chicago, 
Illinois) with significance set at p<0.05. Pre- to post-intervention differences were 
statistically tested using a repeated measures Student’s t-test. Between group 
differences were performed using a one-way ANOVA, with a Bonferoni post-hoc test, 
with significances reported with respect to the H-CON group. Values are presented 
as means ± SD. 
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Results 
 
Neuropathy scores 
Patients within the DPN-INT group displayed significantly higher mNDS (DPN-INT: 
6.2 ± 2.6; D-INT: 2.4 ± 2.1; D-CON: 4.8 ± 4.5; and H-CON: 2.0 ± 1.4; p<0.05) scores 
than the D-INT and H-CON groups, and significantly higher VPT (DPN-INT: 31.0 ± 
5.9 V; D-INT: 8.5 ± 2.7 V; D-CON: 11.8 ± 6.0 V; and H-CON: 11.9 ± 7.0 V; p<0.05) 
scores than the D-INT, D-CON and H-CON groups. 
 
Stepping accuracy (Fig. 2) 
Patients within the DPN-INT and D-INT groups were significantly more accurate at 
stepping post-intervention compared to pre-intervention, contacting the ground 
significantly closer to the centre of the target (pre- vs post-Intervention – DPN-INT: 57 
± 33  vs 31 ± 15 mm [45% increase in accuracy]; and D-INT: 64 ± 29 vs 41 ± 14 mm 
[36% increase in accuracy]). In contrast, the stepping accuracy of the D-CON group 
was unchanged pre- to post-intervention (pre- vs post-Intervention – D-CON: 33 ± 9 
vs 35 ± 7 mm [7% decrease in accuracy]; p>0.05).  
  
Pre-intervention, the DPN-INT and D-INT groups were significantly less accurate at 
stepping than the H-CON group (p<0.05), whereas the D-CON group displayed a 
similar level of stepping accuracy (DPN-INT: 57 ± 33; D-INT: 59 ± 28; D-CON: 33 ± 9; 
and H-CON: 38 ± 31 mm). Post-intervention, no differences in stepping accuracy 
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were observed between the groups (DPN-INT: 31 ± 22 mm D-INT: 41 ± 24mm; D-
CON: 35 ± 20 mm; and H-CON: 38 ± 31 mm; p>0.05). 
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Figure 2. Pre- and Post-intervention results for stepping accuracy (distance between 
2MH and the target centre) for diabetic controls (D-CON; n=6), diabetic intervention 
(D-INT; n=8), and diabetic peripheral neuropathy intervention (DPN-INT; n=5) 
groups. The H-CON bar shows the results without any intervention for the healthy 
control group (H-CON; n=10) as a reference for comparison against the diabetes 
groups. For the D-CON bar, the grey section shows the pre-intervention results, and 
the additional horizontal striped section shows the increase in distance (i.e., reduced 
accuracy post-intervention) post-intervention. For the D-INT and DPN-INT bars, the 
grey bar shows the post-intervention distance, and the vertical striped bar in addition 
to the grey bar shows the pre-intervention distance (i.e., improved accuracy post-
intervention). Values are mean distances and SD; * denotes significantly different 
distance post-intervention compared to pre-intervention (p<0.05). 
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Discussion 
 
This study shows for the first time that resistance exercise and visual gaze training 
can increase stepping accuracy during walking in patients with diabetes and DPN. 
This is expected to translate to an improved ability for patients with diabetes, and 
particularly DPN, to avoid observed obstacles during walking, and may result in a 
reduced risk of tripping and subsequent falling, in this population.  
 
Accurate stepping is dependent upon the combined use of vision and motor control, 
to visually identify the intended position of future foot placement, and subsequently 
control the swing trajectory of the lower limb. Motor control of the lower limbs is highly 
affected by neuropathic damage, as DPN affects not only cutaneous sensation and 
muscle response, but also proprioception of lower limb position, often resulting in a 
reduced postural stability (20, 21). Patients with DPN, as a result of decreased 
proprioception, also display a decreased sense of joint position, which is therefore 
likely to impact upon knowledge of lower limb position and orientation during 
stepping, as well as the swing limb velocity (20). Another important element of motor 
control is the ability to accurately and consistently develop an appropriate level of 
muscle force, to control joint movement. Whilst no research into the effects of 
diabetes or DPN on muscle force steadiness has yet been performed, older adults, 
another population at a high risk of falling, are less steady during submaximal 
isometric contractions (22). This is particularly important during the swing phase of 
stepping where ankle and knee joint moments are very low compared to during the 
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stance phase of gait (23). Furthermore, variability in lower limb motor performance 
during low and medium effort tasks is exacerbated by increased cognitive demand 
(24). The stepping task is likely to increase cognitive demand and is expected to 
notably affect patients with DPN, who use vision for both ‘feed-forward’ planning, as 
well as feedback of foot position, during walking. Furthermore, in the event of a 
potential tripping hazard being presented, cognitive demand would rapidly increase, 
which may therefore affect lower limb performance and subsequent ability to perform 
an avoidance strategy. 
 
Strength training has previously been shown to improve force accuracy and 
steadiness in elderly patients, increasing maximal strength as well as control of 
submaximal strength (25). It also reduces force fluctuations, which are expected to 
improve force steadiness and consequential motor control (26). It is therefore 
expected that as well as increasing maximal strength of the ankle and knee flexors, 
the resistance training exercises may have improved force steadiness and increased 
the control of submaximal muscle force during dynamic tasks, resulting in an 
improved control of joint position and lower limb orientation.  
 
In addition to improvements to motor control, visual gaze strategy is also expected to 
have been altered by the visual gaze training task. Previous studies have shown 
positive responses to visuomotor training by improving postural stability, dynamic 
visual acuity, and stepping accuracy in both healthy young and elderly populations  
(14, 16, 19, 27). The visual gaze training task performed over the 16-week 
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intervention in the present study required participants to visually map the route before 
stepping onto the irregularly placed stepping targets. This was expected to 
encourage a ‘feed-forward’ planning of the stepping route, which during walking 
would cause patients to continuously survey the upcoming environment, allowing 
patients to observe and subsequently avoid potential tripping hazards. This would 
allow participants to consider the location of upcoming targets as well as the next 
immediate target, allowing more time to co-ordinate appropriate responses for the 
future (28). Using the same methods as those presented in Chapter 4, the effects of 
the visual gaze intervention on visual gaze parameters were measured in a subset of 
intervention patients (n=3; D-INT=2 and DPN-INT=1), who improved stepping 
accuracy by a mean average of 173%. Visual gaze timings were altered as a result of 
the intervention, with patients looking away to the subsequent target earlier, and 
taking less time to look between targets, consequently resulting in patients acquiring 
the next target earlier (Fig. 3). These visual gaze characteristics indicate that patients 
were able to spend longer assessing the target position on approach, and may at 
least in part, have contributed to the improved stepping accuracy observed. These 
are, however, only preliminary observations in a small sample size, but the consistent 
and clear direction of the changes at least provide some insight into the potential 
mechanism for the improved stepping accuracy and a stimulus for further research.      
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Figure 3. Target visual acquisition parameters during the stepping task, pre- (PRE D-
INT) and post-intervention (POST D-INT) for the combined diabetic patient 
intervention group, and shown in comparison to healthy controls (H-CON) as a 
reference. Values are means and standard deviations as a percentage of the visual 
gaze cycle. The black bars denote visual acquisition of the target, the white bars 
denote the time looking between targets, and the end of the white bar denotes the 
acquisition of the next target. Foot-ground contact occurs at 0%. 
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This study has shown that stepping accuracy can be improved through high-load 
resistance exercise and visual gaze training. Future studies should look to elucidate 
the separate effects of the high-load resistance exercise and visual gaze training 
components on motor control and visual gaze strategy. Such work may help to 
further focus exercise regimens and aid the production of an all encompassing, yet 
short and enjoyable intervention regimen that patients with diabetes and DPN can 
perform to improve their safety in a real-world environment. Furthermore, I theorise 
that the observed increases in stepping accuracy are indicative of an increased ability 
to avoid tripping hazards, and therefore this specific hypothesis should be tested 
experimentally by future studies. The findings of this study provide further evidence of 
resistance exercise training being beneficial to patients with diabetes and DPN, and 
in combination with visual gaze training, the performance of these training tasks may 
reduce the risk of tripping on observed obstacles. This multi-faceted intervention 
could be considered as part of a clinical treatment programme to improve the general 
health and safety of patients with diabetes. 
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Chapter 6 
 
Conclusions and future directions 
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Summary of main findings 
The central aim of this thesis was to examine why patients with DPN are more likely 
to fall than age-matched controls, and to examine the efficacy of a multifaceted 
intervention on reducing the risk of falling in this population. The general finding of 
the work from this thesis was that a targeted multifaceted intervention improves 
factors that have been linked to an increased risk of falling in patients with diabetes 
and DPN.  
 
In chapter two it was observed that patients with DPN are slower at generating 
strength at the ankle and knee than control participants during stairs ascent and stair 
descent. These changes were theorized to be caused by altered activations of the 
extensor muscles which may increase the likelihood of instability. In chapter three it 
was then found that the performance of resistance exercises, once a week for sixteen 
weeks, resulted in increases in SoSG of the ankle and knee. This is expected to 
improve stability during the crucial weight acceptance phase of stair ascent and 
descent, and ultimately contribute towards reducing the risk of falling. Improvements 
in strength as a result of the resistance exercise training intervention are expected to 
be the most influential factor for increasing the SoSG. 
 
In chapter four, it was found that patients with DPN display a reduced stepping 
accuracy, which may lead to patients with DPN being less able to avoid observed 
obstacles during walking. However, patients also displayed an increased toe 
clearance, which is expected to reduce their likelihood of tripping on smaller, less 
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observable potential trip hazards. Preliminary analysis of visual gaze characteristics 
indicated an altered visual strategy in patients with DPN compared to controls during 
stepping, which together with impaired motor control may underlie the changes in 
stepping accuracy. In chapter five I demonstrated that the performance of an 
intervention consisting of resistance and visuomotor exercises improved stepping 
accuracy in patients with diabetes and DPN. This is expected to translate to an 
improved ability to co-ordinate the appropriate response to avoid a potential tripping 
hazard. The improvements in stepping accuracy are expected to be the result of 
improvements in motor control and visual gaze strategy. 
 
Both aspects of the intervention, the high load resistance and visual gaze training 
elements, are expected to have contributed to improvements in biomechanical 
characteristics indicating a reduced risk of falling. The visual gaze exercise 
performed by participants is a novel technique, unusual to the area of diabetes, and 
appears to contribute to increasing stepping accuracy in patients with diabetes and 
DPN. Whilst the data presented was preliminary due to the small cohort examined, 
the results are promising, and appear to indicate an altered visual gaze strategy, 
approaching that used by healthy controls. It is expected that these observations 
would be reinforced in a larger cohort, and it is therefore suggested that future 
studies should look at the sole effect of visual gaze training on stepping accuracy, in 
the absence of other training methods such as resistance exercise. 
 
Page | 165  
 
Resistance training was suggested to potentially be the most important component of 
the intervention, by improving muscle strength, which contributes to improvements in 
SoSG and motor control during stair negotiation and level ground walking, 
respectively. Therefore, resistance training may be the key exercise for patients with 
diabetes, and particularly those with DPN, by helping to improve markers indicative of 
fall risk, walking ability, and postural stability.  
 
 
Further findings of interest 
An interesting and unexpected finding was the apparent ability of patients to retain 
strength over a two-week period. On the rare occasions where patients were unable 
to attend a session for a given week, they were able to retain the same level of 
strength (indicated by the ability to perform the resistance exercises using the same 
weight as the previous week) on their return, as discussed in chapter 3. One of the 
potential reasons for this could be the increased self-reported activity; as by 
improving muscle strength, patients were able to be more active, which therefore 
contributed to further improvements in fitness. These findings may indicate that 
patients may only need to exercise for one hour, twice a month, to retain levels of 
strength beneficial to reducing the risk of falling during locomotor tasks. 
  
In addition to this, and contradictory to the typical approach to weight loss, I 
speculate that resistance training may also be a beneficial approach to reducing 
weight and improving metabolic control in patients with diabetes and DPN. Whilst it 
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was not measured in this thesis, previous studies have identified a number of factors, 
which in combination, lead me to this concept. Resistance training improves muscle 
quality and muscle volume, and has previously been shown to improve glycaemic 
control and control blood pressure (1-5). Furthermore, as observed in the patients 
who undertook the intervention, improvements in muscle strength encouraged and 
allowed patients to increase activity levels, which may lead to further weight loss. 
Such training has also been identified as a more enjoyable form of exercise, and may 
provide a method of getting more patients exercising than if solely aerobic exercises 
were prescribed (6). Therefore, resistance exercise may be the ‘holy grail’ for patients 
with diabetes and DPN, allowing improvements in a number of important areas which 
may improve safety, health and well being.  
 
 
Clinical Implications  
As stated in the background of this thesis, secondary complications are common in 
patients with diabetes. Whilst DPN is the most common of these complications, it is 
not necessarily always the main concern of patients and clinicians. Retinopathy, 
nephrology, and cardiovascular diseases are often observed in patients who have 
had diabetes for a long period of time. Therefore the management of neuropathy 
must be something that is considered alongside other treatments. 
 
As stated in the previous section, resistance exercise may be the ‘holy grail’ for 
patients with neuropathy. Not only allowing the improvements in safety, but also 
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facilitating potential important increases in activity levels and subsequent 
improvements in weight and blood pressure control. The design of this study to make 
the results as real-world applicable as possible means that the results observed are 
expected to be directly reproducible by clinicians and physiotherapists. The length 
and frequency of the sessions mean that they are as manageable as possible for 
people of all ages and conditions, and for patients of all levels of employment. The 
small number of resistance exercise machines required, and the fact that they are 
common machines found in commercial gyms, as well as clinically based gyms, 
means that patients of all levels of diabetes and neuropathy will be available to 
perform such exercises. If performed in a clinical setting, it is important that the gym 
environment created is different to that typically experienced in commercial gyms. A 
friendly and more enjoyable approach to exercise should be developed. Trainers and 
physiotherapists should build bonds with patients to gain their trust and hopefully 
develop their patients understanding of how resistance exercise and increased 
activity levels can improve their lives and diabetic condition. Motivation is crucial in 
patients who in a large number of cases will have developed diabetes through 
inactivity and a sedentary lifestyle.  
 
An important side effect of the intervention is the increase in self-reported activity. 
Previously, sedentary individuals were unable to walk for long distances and perform 
normal everyday tasks, expectedly as a result of reduced muscle strength. This 
meant that muscle strength could not be increased and therefore created a cycle of 
inactivity. The increases in muscle strength as a result of the intervention meant that 
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patients were able to walk for longer, play with grandchildren and go shopping with 
friends and family. All of these activities were manageable, and patients felt that they 
could then maintain the performance of these activities without the performance of 
the intervention exercises after the 16-week period. This is particularly important as 
this may mean that patients with diabetes can build muscle strength over a three 
month period to build ‘base’ muscle strength, which can then be maintained through 
a more active lifestyle consisting of low intensity everyday tasks typical to everyday 
life in the general population. This may imply that the intervention is a cost-effective 
proposition to national health bodies. However, it should be noted that the cost-
effectiveness of the intervention used in the present study was not investigated, 
hence, it is hoped that this will be examined in future studies. 
  
An important aspect of the intervention was that typically, only the more motivated 
patients chose to take part, which could be observed as contributing to why such 
large improvements post-intervention in SoSG and stepping accuracy were 
observed. However, this is also reflective of real-life where only the more motivated 
patients who want to improve their condition will perform the exercises. It is hoped 
that the presentation of our results may be a ‘carrot’ to patients and that positive 
results from friends and family who undertake an intervention may be persuasive for 
them to also take part. Whilst not a ‘quick-fix’, the intervention is non-
pharmacological, non-invasive and manageable, which to a lot of patients may prove 
an attractive proposition. Furthermore, this means that it will not conflict with any 
medication taken to control other aspects of diabetes and its complications.       
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Risk of ulceration and management of ulceration are important considerations for any 
patients performing these exercises. Unlike cardiovascular exercises that are 
typically load bearing and cause the feet to be repetitively in contact with a surface 
for prolonged periods of time, resistance exercises require only short bursts of 
contact with a surface, and when performed using the correct technique, pressure 
should be distributed across the feet. Feet should be checked before and after 
exercise, and correctly fitted trainers should be worn at all times. Furthermore, if any 
signs of ulceration, or a potential risk for ulceration are observed then exercises 
should not be performed and medical advice should be sought.  
 
Even if patients are not able to perform the exercises proposed by this study, certain 
strategies and considerations can be made which would improve their safety during 
everyday life. Where possible, handrails should be used when negotiating staircases, 
and stairways should be brightly lit (as it is assumed that these factors will improve 
safety). Where this is not possible, patients should take more care in maintaining a 
safe and stable pattern of locomotion, although neuropathy may considerably hinder 
this. 
 
My advice for doctors and clinicians would be to prescribe the resistance exercise 
program presented in chapters three and five to patients who are currently unstable 
and at a high risk of falling, but who are also driven to improve their condition. Such 
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exercise is expected to be multi-faceted in helping to improve patients’ safety and 
day-to-day life. 
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